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ON INTELLECTUAL OUTCOME IN PEDIATRIC BRAIN-TUMOR PATIENTS 
 
 
by 
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Under the Direction of Yu-Sheng Hsu 
 
ABSTRACT 
 
Receiver operating characteristic (ROC) curves have been widely used in evaluation of 
the goodness of the diagnostic method in many study fields, such as disease diagnosis in 
medicine. The area under the ROC curve (AUC) naturally became one of the most used variables 
in gauging the goodness of the diagnosis (Mossman, Somoza 1991).  
Since medical diagnosis often is not dichotomous, the ROC curve and AUC need to be 
generalized to a multi-dimensional case. The generalization of AUC to multi-class case has been 
studied by many researchers in the past decade. Most recently, Nakas & Yiannoutsos (2004) 
considered the ordered d classes ROC analysis by only considering the sensitivities of each class. 
 Hence, their dimension is only d. Cha (2005) considered more types of mis-classification in the 
ordered multiple-class case, but reduced the dimension of Ferri, at.el. from d(d-1) to 2(d-1). 
In this dissertation we are trying to adjust and calculate the VUS for an ordered multiple-
class with Cha’s 2(d-1)-dimension method. Our methodology of finding the VUS is introduced. 
We present the method of adjusting and calculating VUS and their statistical inferences for the 
2(d-1)-dimension. Some simulation results are included and a real example will be presented. 
Intellectual outcomes in pediatric brain-tumor patients were investigated in a prospective  
longitudinal study. The Standard-Binet Intelligence Scale-Fourth Edition (SB-IV) Standard Age 
Score (SAS) and Composite intelligence quotient (IQ) score are examined as cognitive outcomes 
in pediatric brain-tumor patients. Treatment factors, patient factors and time since diagnosis are 
taken into account as the risk factors. Hierarchical linear/quadratic models and Gompertz based 
hierarchical nonlinear growth models were applied to build linear and nonlinear longitudinal 
curves. We use PRESS and Volume Under the Surface (VUS) as the criterions to compare these 
two methods. Some model interpretations are presented in this dissertation. 
 
 
 
INDEX WORDS: ROC curve, Volume under the surface (VUS), Longitudinal data, 
Standard Binet Intelligence, Hierarchical linear model, Gompertz 
growth model, PRESS, Pediatric brain tumors 
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CHAPTER 1 
Introduction of ordered ROC analysis 
 
In order to support a decision from researchers in the field of medicine, classification and 
its accuracy with a diagnostic test have been considered as one of the most important processes in 
the study. When their decisions or predictions are incorrect in a diagnosis of a patient, costs of 
misclassification could be enormous. Thus, both avoiding misclassification and increasing 
accuracy can be the goal in medical decision making. 
Receiver Operating Characteristic (ROC) curve has been used as a tool in distinguishing 
the quality of given classifier in diagnostic tests for years. ROC analysis was developed to 
describe and summarize the data from electronic signal detection (Tanner & Swets, 1954; Egan, 
1975). Nowadays, it has been used in the biomedical applications to evaluate the accuracy of 
diagnostic and prognostic technology (Hand & Till, 2001, Mossman, 1991). 
The area under the ROC curve that can be calculated with sensitivities and specificities at 
various cutoff points is used for the evaluation of the misclassification. Sensitivity is defined as  
the proportion of cases correctly identified by the test among all positives (e.g. the proportion of 
positive tests among all disease patients), and specificity is defined as the proportion of cases 
correctly identified by the test among all negatives. ROC curve is a graph of sensitivity versus 
one minus specificity at all cutoff points. According to James Hanley (1982), the area under the 
ROC curve (AUC) implies a single quantitative index to reduction of entire ROC curve to 
quantify a diagnostic accuracy with the information of entire ROC curve. However, most of ROC 
analysis and AUC have been restricted to a classifier with just two classes. 
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However, we are often encountered with the medical problems in which there are more 
than two classes. Srinivasan (1999) extended three classes problem to 6-dimensional ROC 
surface using the six misclassification cells as the six dimensions. To compute the volume under 
the ROC surface (VUS), we need to find the volume of the convex hull generated by n points in 
the six dimensional spaces. Using some existing computer software, we can compute the volume 
of the convex hull. However, it is very easy to miss some points in constructing the convex hull 
due to these high dimensional surfaces, i.e. six dimensions in three classes. Hand & Till (2001) 
used the average of all possible paired comparisons to extend the case of more than two classes 
and reduce their measure to the standard form in the two classes. In addition, Mossman (1999) 
presented an approximation for the three classes based on a priorisation of one of them. Ferri, 
Hernandez-Orallo, and Salido (2003) [1] proposed a complete solution of multi-dimensional 
problems of ROC analysis using again all misclassification cells as dimensions. They presented 
the trivial classifiers, the maximum and minimum of the VUS in the extension of AUC to the 
three and more classes. They introduced the method of Hyperpolyhedron Search Algorithm 
(HSA). However, their paper, also, has shown the theoretical limitation of computing the 
maximum volumes in the high-dimensional problem and at least d(d-1) dimensional variable for 
d classes are needed for obtaining their volumes. All the above works are treating each class 
equally. Although the costs for each misclassification can be assigned, they never can be 
embedded in the structure of VUS. In other words, they can not be applicable for d ordered 
classes. 
 Most recently, Nakas & Yiannoutsos (2004)[2] considered the ordered multiple-class 
ROC analysis by only considering the sensitivities of each class. Hence, their dimension for 
obtaining their volumes is only d for d classes. However they did not consider the specificities. 
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Cha (2005) [3] considered more types of mis-classification in the ordered multiple-class case, but 
reduced the dimension of Ferri, at.el. to 2(d-1). Also she uses Qhull method to compute the 
multi-dimensional volume. The computation can be time consuming and has no mathematical 
expression for the estimation. Also, no inferences were derived. 
In the first five chapters of dissertation, we are trying to define and calculate the VUS for 
an ordered multiple-class with Cha’s 2(d-1)-dimension method. In chapter 2, our methodology of 
definition and estimation of the VUS is introduced in 3 classes’ case. Also a short example will 
be stated in this chapter. We present the method of making inference to VUS for 3 classifier case 
in chapter 3. We extend our conclusion to any number of classifiers in chapter 4. Some 
simulation results are included in chapter 5. The chapter 6, 7 and 8 will present a longitudinal 
data analysis with application of VUS. The last chapter will give the conclusion and future 
research. 
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CHAPTER 2 
New VUS definition and estimation 
 
2.1 Previous research conclusion 
We start with a 2-class diagnosis case.  
Sensitivity and specificity are used to evaluate the accuracy of a diagnostic or 
classificatory tool. Sensitivity is the proportion of correctly diagnosed positives among all true 
positives. Specificity is the proportion of correctly diagnosed negatives among all true negatives 
(Walld, 2001). These values can be illustrated in the following tables: 
 
Table 2.1 2-class diagnosis table 
Diseased Status  
Positive Negative 
Positive #n TP 
(True Positive) 
#n FP 
(False Positive) 
Test 
Negative #n FN 
(False Negative) 
#n TN 
(True Negative) 
 
Then we have  
Sensitivity=P (diagnosed Positive| Disease) 
Specificity=P (diagnosed Negative| Non-disease) 
 
5 
 
Let iX  be the continuous random variable used to diagnose a certain disease with 1=i  
representing it was from the disease class and 2=i  representing the benign class, respectively. 
The sensitivity and the specificity can be expressed as 
)( 1 CXPySensitivit ≤=  and  
)( 2 CXPySpecificit ≥=  for a cutoff point C . 
 Bamber (1975) [4] proved that  
∫=
1
0
ysensitivitAUC )1( yspecificitd −  
∫ ≤≤=
1
0
21 )()( CXdPCXP  
)( 21 XXP ≤=                                                         (2.1.1) 
We can also derive the AUC by expectation. First, let iX  be the diagnosis result (fix 
number) of a certain disease with 1=i . The sensitivity and the specificity can be expressed as  
11 )( UCXIySensitivit =≤=  and  
22 )( UCXIySpecificit =≥=  for a cutoff point C , 
where I  is the indicator function. 
     Similar to Bamber’s proof,  
        ∫ ∫∫ ==
1
0
1
0
21
)(
0
2121
1
),( dUUdUdUXXh
CU
 
                ∫
+∞−∞∈
≥≤=
),(
21 )()(
C
CXdICXI  
                  )( 21 XXI ≤=                                              (2.1.2) 
Then we take expectation to ),( 21 XXh  we can get  
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        AUCXXPXXhE XX =≤= )(),( 2121),( 21                                (2.1.3) 
We call )( 1 CXI ≤  and )( 2 CXI ≥  the kernel of sensitivity and specificity separately 
and ),( 21 XXh  the kernel of AUC. 
 
Let },....1|{ 11 niX i =  and },....1|{ 22 njX j = be two random samples from “disease” and 
“benign” populations, respectively. Then the estimated AUC can be expressed as   
             ∑∑
= =
≤=
1 2
1 1
21
21
^
)(
1 n
i
n
j
ji XXI
nn
AUC                               (2.1.4) 
 
This scheme can be generalized to 3-class case as follows: Let the three classes be 
“Disease (D)”, “Suspicious (S)” and “Benign (B)”. Also, let 
iX  be the classifier in three 
populations with i=1, 2 and 3 representing D, S and B respectively. If we use C1 and C2 as the 
cutoff points ( 21 CC ≤ ), then we have similar table as 2-class case, where we use “h” as 
sensitivities and “F” as mis-classified probabilities. 
 
Table 2.2 3-class diagnosis table 
Actual diseased Status  
Disease Suspicious Non-Disease 
Positive      ha     F1     F2 
suspicious     F3     hb     F4 
Test 
Negative     F5     F6     hc 
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Then we have  
Sensitivity1 = P (diagnosed D | D)= )()( 111 UECXP =≤ ,                     (2.1.5) 
Sensitivity2 = P (diagnosed S | S)= )()( 2221 UECXCP =≤≤ ,                 (2.1.6) 
Sensitivity3 = P (diagnosed B | B)= )()( 323 UECXP =≥ ,                     (2.1.7) 
Here, )( 111 CXIU ≤= , )( 2212 CXCIU ≤≤= ,and )( 233 CXIU ≥=  are the kernels. 
If we ignore the various mis-classifications, i.e. no specificities are concerned, then the 
VUS can be expressed as, see Nakas & Yiannoutsos (2004): 
)( 321312
21
XXXPtydSensitivitydSensitiviySensitivitVUS
CC
≤≤== ∫∫
≤
            (2.1.8) 
 
Also, we can first considered 321 ,, XXX  as fixed diagnosis for the three classes and use 
the kernels of the sensitivities to derive the kernels of VUS and take expectation to find VUS  
)(),,( 321312321
21
XXXIdUdUUXXXh
CC
≤≤== ∫∫
≤
 
)(),,( 321321),,( 321 XXXPXXXhEVUS XXX ≤≤==                            (2.1.9) 
 
The estimate of VUS can be expressed as 
∑∑∑
= = =
==
1 2 3
321
1 1 1
321
321
,, );;(
1ˆ
n
i
n
j
n
k
kjinnn XXXh
nnn
Uδ ∑∑∑
= = =
≤≤=
1 2 3
1 1 1
321
321
)(
1 n
i
n
j
n
k
kji XXXI
nnn
 
                                                                       (2.1.10) 
where },...,1|{ iij njX = and i=1, 2, 3 are three random samples from D, S, and B population, 
respectively. 
The U-statistics kernel is );;( 3211 XXXh .  
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Using the fact that VUSXXXhE =)),,(( 3211  and applying the Central Limit Theorem, 
we have 
                ),0()( 2,,321 321 σNVUSUnnn
L
nnn →−++ .                     (2.1.11) 
 
2.2 New proposed method 
If all six different mis-classifications are considered, then the surface is in a six 
dimensional space. For an ordered multiple-class case, we propose a four dimensional surface as 
follows: 
 
Sensitivity1=P (diagnosed D | D)                                        (2.2.1) 
Specificity1=P (diagnosed S or B | S or B)                                 (2.2.2) 
Sensitivity2=P (diagnosed D or S | D or S)                                 (2.2.3) 
Specificity2=P (diagnosed B | B)                                        (2.2.4) 
 
This setup is combining P(diagnosed D| S) and P(diagnosed D| B) into P(diagnosed D| S 
or B), and the method was motivated by assuming the following usual facts: 
P(diagnosed D| S or B)>>P(diagnosed D| B), P(diagnosed B| S or D)>>P(diagnosed B| D). 
This is because D, S and B are ordered. 
We may construct the surface by four kernels 1U , 2U , 3U , and 4U , assuming all 3 
classes have equal probability to occur: 
)()(
2
1
)(
2
1
1 1131211 UECXPCXPySpecificitW =≤+≤=−=  
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with )(
2
1
)(
2
1
13121 CXICXIU ≤+≤=                   (2.2.5) 
)()(1 22322 UECXPySpecificitW =≤=−=    with )( 232 CXIU ≤=          (2.2.6) 
)()(1 31113 UECXPySensitivitW =≥=−=     with )( 113 CXIU ≥=           (2.2.7) 
)()(
2
1
)(
2
1
1 4222124 UECXPCXPySensitivitW =≥+≥=−=      
with )(
2
1
)(
2
1
22214 CXICXIU ≥+≥= .                 (2.2.8) 
According to the representation of two cases above, we can define and express VUS as 
)(
21
4321∫ ∫∫∫
≤
=
CC
dUdUdUdUEVUS .                            (2.2.9) 
Here  ∫ ∫ ∫ ∫∫ ∫∫∫
+∞−∞∈ −∞∈ +∞∈ −∞∈≤
≡
),( ),( ),( ),(
43214321
2 21 12 2121 C CC CC CCCC
dUdUdUdUdUdUdUdU  
 
(We can also define VUS directly by integration of Wi’s but the estimate of it will be 
quite difficult. Therefore, we use mean of kernel integration to simplify it and make the inference 
possible.) 
 
Theorem 1. With the set up as stated above and assuming equal probabilities from each of the 
three classes, the estimated VUS is 
^
VUS ∑∑∑
= = =
+≤≥+≤=
1 2 3
1 1 1
211332
321
))
2
1
)()(()
2
1
)((
4
11 n
i
n
j
n
k
jiikkj XXIXXIXXI
nnn
,  
                                                                       (2.2.10) 
where },...,1|{ iij njX = and i=1, 2, 3 are three random samples from D, S, and B population, 
respectively. 
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Proof: 
∫∫ ∫∫∫
+∞−∞∈≤
==
),(
434321321
221
),,(
CCC
dUAdUdUdUdUXXXh  
where ∫
−∞∈
=
),(
323
21 CC
dUAA , ∫
+∞∈
=
),(
212
12 CC
dUAA , ∫
−∞∈
=
),(
11
21 CC
dUA                        (2.2.11) 
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2322
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2
1
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1
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1
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232322
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2
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1
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1
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2
1
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2
1
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==
),(
434321321
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        ))()(()()()
2
1
)((
4
1 1
0
2221211332 ∫ ≤+≤≤≥+≤= CXICXIdCXIXXIXXI  
)
2
1
)()(()
2
1
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4
1
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Then, 
))
2
1
)()(()
2
1
)((
4
1
( 211332 +≤≥+≤= XXIXXIXXIEVUS                    (2.2.16) 
To estimate VUS: 
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Theorem 2. Let 321 ,, aaa  be the probabilities in D, S, and B, respectively. Then for 
1321 =++ aaa , we have the estimated VUS as 
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Proof  
Here we consider different probabilities from each of the three classes, then we need to 
re-define sU i '  and sWi '  as follow: 
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)()(1 22322 UECXPySpecificitW =≤=−=    with )( 232 CXIU ≤=         (2.2.20) 
)()(1 31113 UECXPySensitivitW =≥=−=     with )( 113 CXIU ≥=         (2.2.21) 
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To estimate VUS: 
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Corollary1. The new proposed VUS is the linear combination of AUC which includes 
suspicious class into disease class, AUC which includes suspicious class into benign class, AUC 
which exclude suspicious class and VUS proposed by Nakas & Yiannoutsos (2004). 
 
Proof 
From (2.2.27)  
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where )( 321 XXXPVUS NY ≤≤=  is the VUS proposed by Nakas & Yiannoutsos 
(2004), ),( 312132 XXXXPAUC ≤≤=− is the AUC which includes suspicious class into benign 
class, ),( 323112 XXXXPAUC ≤≤=−  is the AUC which includes suspicious class into disease 
class, and )( 312 XXPAUC ≤=−  is the AUC which excludes suspicious class. 
 
Corollary2. The maximum and minimum values of VUS in Theorem 2 can be found as: 
))((
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VUSMax
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2
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aaaaaaa
VUSMin ++
+++
= . 
                                                                       (2.2.28) 
The corollary can be shown when we replace NYVUS , 32−AUC , 12−AUC  and 2−AUC  by 
1 in corollary1 for the maximum volume case. For minimum volume case, we can also prove it 
by treating probabilities of any order of },,{ 321 XXX  to be 1/6 . 
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2.3 Performance and advantage of new proposed VUS 
From corollary2 in 2.2 we can find that the new proposed VUS (denote by NEWVUS ) is 
the linear combination of four criteria NYVUS , 32−AUC , 12−AUC  and 2−AUC  (Defined in 
Corollary 1 of the last section). If we consider unweighted case,  
21232
16
1
8
1
8
1
4
1
−−−
+++= AUCAUCAUCVUSVUS NYNEW                  (2.3.1) 
Here 
NYVUS  has highest weight because it included 3 classes and therefore loss less 
information. 32−AUC  and 12−AUC  have lower weight because it is calculated by including 
suspicious class into benign class or disease class and therefore loss more information than 
NYVUS . 2−AUC  has lowest weight because it is calculated by excluding suspicious class into 
consideration and therefore loss more information than 32−AUC  and 12−AUC . Also you can 
adjust the weight by using weighted formula in corollary2 according to different consideration. 
The new proposed 
NEWVUS  is clearly better than 32−AUC , 12−AUC  and 2−AUC  
because it takes suspicious class into consideration. Also NEWVUS  is better than NYVUS  
because in NEWVUS  we consider both sensitivity and specificity but in NYVUS  we only 
consider sensitivity. We can use a simple example to show the advantage of NEWVUS  to 
NYVUS  
Consider a three-level screening test index. It is screened to be benign if the value of 
index is between 0 and 1; It is screened to be suspicious if the value of index is between 1 and 
1.5 and it is screened to have disease if the value of index is greater than 1.5. For simplicity, we 
consider 3 individuals to have the tests, one of which is in benign class (the test index is denoted 
by 1X ), one of which is in suspicious class (the test index is denoted by 2X ), one of which is in 
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disease class (the test index is denoted by 3X ). Now we have 2 different tests. In test 1, 
0,2.1,5.0 321 === XXX . In test 2, 1.1,2.1,5.0 321 === XXX .In both of this two tests, the 
benign and suspicious classes are corrected screened but disease class is not. The difference is 
that in test 1, the disease class is screened to benign and in test 2, the disease class is screened to 
suspicious. Therefore, it is clear that test 2 is better than test 1. Let’s use 
NEWVUS  and NYVUS  
to measure these two tests. It is easy to compute that 0
)2()1(
== NYNY VUSVUS , 
16
3
,0
)2()1(
== NEWNEW VUSVUS . Then, NYVUS  fails to measure the difference between test 1 
and test 2 but NEWVUS  can. 
The table below show the performance of VUS proposed by Nakas & Yiannoutsos (2004) 
and new proposed VUS for difference test result. 
 
Table 2.3 Performance comparison for 1:1:1 population proportion 
Test   NYVUS  32−AUC  12−AUC  2−AUC  NEWVUS  
321 XXX <<     1    1    1    1    
16
9
 
231 XXX <<     0    1    0    1    
16
3
 
312 XXX <<     0    0    1    1    
16
3
 
132 XXX <<     0    0    0    0    0 
213 XXX <<     0    0    0    0    0 
123 XXX <<     0    0    0    0    0 
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Also it is available to adjust the value of new proposed VUS by adjusting the population 
proportion of the three classes. For instance, let the population proportion of class “benign”, 
“suspicious” and “disease” is 2: 1: 1, which means here are more “benign” cases than 
“suspicious” and “disease”. Then  
21232
12
1
6
1
12
1
6
1
−−−
+++= AUCAUCAUCVUSVUS NYNEW                   (2.3.2) 
Similar to above, we can see the performance of VUS proposed by Nakas & Yiannoutsos 
(2004) and new proposed VUS for difference test result (only 3 individuals in 3 classes 
separately): 
 
Table 2.4 Performance comparison for 2:1:1 population proportion 
Test 
NYVUS  32−AUC  12−AUC  2−AUC  NEWVUS  
321 XXX <<  1 1 1 1 
2
1
 
231 XXX <<  0 1 0 1 
6
1
 
312 XXX <<  0 0 1 1 
4
1
 
132 XXX <<  0 0 0 0 0 
213 XXX <<  0 0 0 0 0 
123 XXX <<  0 0 0 0 0 
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Apparently, test I make perfect decision, then the VUS value will be the highest value. 
Comparing test II and test III, test II reverse class 2 and 3 and correctly diagnose class 1; test III 
reverse class 1 and 2 and correctly diagnose class 3. Here NEWVUS  for test III performs better 
than test II because population size of class “benign” is larger, then in test II, the correctly 
diagnosis for class “benign” is by more chance.  
 
2.4 A real example 
In this section, we illustrate the application of the proposed new method for the sensitivity 
and specificity in 3 classes with the real ordered data. Cervical cancer is one of the most common 
cancers for women, and is also one of the easiest one to recover among all cancers, if it can be 
treated early. Thus, it is important to diagnose the cervical cancer early with accuracy. There are 
two main diagnostic tests, Pap smear and Colposcopy that are used in the diagnosis of Cervical 
Cancer. Current routine screening diagnosis is Pap smear, which can detect precancerous and 
cancerous cells on the cervix. If the Pap test has unclear result for abnormality, then the doctor 
may request to perform that test again. If Pap smear shows the significant abnormality, the 
Colposcopy that required the extensive training, experience and a significant effort in order to 
check for any abnormalities of the tissue surrounding the vagina and cervix may be requested to 
perform. However, these tests have many disadvantages such as excessive time consumption, 
economic inefficiency and low accuracy etc. In general, only 0.1% of about 10% of women who 
were identified to have abnormal tissue in the cervix in Pap smear proved to present abnormality. 
In addition, the abnormal and cancerous cells are missing in the half of Pap smear test result due 
to sampling errors. Thus, the earlier and more accurate detection for cervical cancer can help 
reduce the risk of death. 
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Spectrx, Inc. has developed a non-invasive method to diagnose cervical cancer. They used 
fluorescence and reflectance spectroscopy technology to produce a fiber optical and camera 
system. The system was introduced in 1999, and the hybrid device was developed from 2002 to 
2006. There were 648 patients participated in the multicenter clinical trial. The device collected 
data from 56 spatial points on a circle surface of the cervix for each patient. The more detailed 
data collection and their variables can be seen in [5, 6]. The gold standard pathology yields the 
values 0, 1, 2, 2.5, 3, 3.2 and 3.5 for this response variable. The Food and Drug Administration 
(FDA) classifies {0, 1} as normal, {3, 3.2, 3.5} as cancer. However, {2, 2.5} can be classified as 
either normal or disease. With this ambiguous classification, Spectrx decided to delete these 
patients in the data set. Therefore, the problem becomes dichotomy, and the usual AUC can be 
easily used as the basis to select the model. We like to know if we treat {2} as the class between 
disease and normal, will we select the same model or not? In this case, our VUS can be applied 
as a three-class case. We used same models as previous studies (see [5]) but including all patients 
with gold standard value 2 as the suspicious class. We also used the same 10-fold cross 
validation techniques to estimate the shrinkages of each model. The VUSs were used to select the 
model. In many situations the selections are reverse the selection by AUCs. Since it became a 
four dimensional volume instead of two dimensional area, the maximum and minimum values of 
VUS are much smaller than that of the AUC. In order to make a more comparative numbers, we 
transformed VUS using both linear and quadratic formulae. 
All models included not only the standardized original variables, but also many Boolean 
algebraic transformed variables. Since the variables are kind of lengthy, we do not list them here. 
However, they can be seen in [5, 6]. The comparison results are shown in the following table. We 
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may see we select model 1.03, while AUC select model 1.04 in the series model 1. We select 
model 2.12 instead model 2.11 selected by AUC in the series model 2. 
 
Table 2.5 AUC and VUS for some models in cervical cancer diagnosis example 
 
Model Type AUC VUS Mapping_VUS 
     (linear) 
Mapping_VUS 
(Quadratic) 
1.03 Training 0.869336 0.294819 0.747506494 0.780501572 
 10x validation 0.843569 0.272403 0.709680536 0.743149032 
1.04 Training 0.861435 0.297352 0.751780985 0.784631895 
 10x validation 0.840525 0.272853 0.710439835 0.743913632 
2.0 training 0.763041 0.247273 0.667272926 0.699394165 
 10x validation 0.762792 0.247196 0.667143249 0.699257042 
2.1 training 0.759681 0.247144 0.667055008 0.699163720 
 10x validation 0.758400 0.246780 0.666441140 0.698514238 
2.11 training 0.792451 0.259172 0.687352900 0.720376263 
 10x validation 0.789141 0.254386 0.679276543 0.711996201 
2.12 training 0.796061 0.260739 0.689997149 0.723103106 
 10x validation 0.775284 0.258856 0.686818805 0.719824485 
2.13 training 0.796543 0.258079 0.685508837 0.718469718 
 10x validation 0.784567 0.256242 0.682408718 0.715255439 
2.14 training 0.791886 0.258559 0.686318313 0.719307117 
 10x validation 0.780874 0.257897 0.685201403 0.718151475 
2.15 training 0.792185 0.256649 0.683094709 0.715967681 
 10x validation 0.781040 0.252838 0.676664713 0.709269313 
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CHAPTER 3 
Inference of new VUS 
3.1 Multi-sample U-statistics 
The basic theory of U-statistics was developed by Hoeffding (1948a). Detailed 
expositions of the general topic may be found in Denker (1985) and Lee (1990). See also Fraser 
(1957) Chapter 6, Serfling (1980) Chapter 5, and Lehmann (1999) Chapter 6. 
We say that )(Pθ  is an estimable parameter within P which is a family of probability 
measures on an arbitrary measurable space, if for some integer m there exists an unbiased 
estimator of )(Pθ  based on m i.i.d. random variables distributed according to P; that is, if there 
exists a real-valued measurable function ),...,( 1 mxxh  such that )()),...,(( 1 PXXhE mP θ=  for 
all P, when 
mXX ,...,1  are i.i.d. with distribution P. The smallest integer m with this property is 
called the degree of )(Pθ . 
For a real-valued measurable function, ),...,( 1 mxxh  and for a sample nXX ,...,1 , of size 
mn ≥  from a distribution P, a U-statistic with kernel h is defined as  
∑
−
==
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m
P
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n
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1
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!
)!(
)(                           (3.1.1) 
where the summation is over the set nmP ,  of all n!/(n-m)! permutations ),...,( 1 mii  of size m 
chosen form (1,2,…,n). If the kernel, h, is symmetric in its arguments, 
nU  has the equivalent 
form  
            ∑
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Where the summation is over the set nmC ,  of all 





m
n
 combinations of m intergers, 
miii <<< ...21  chosen from (1,2,…,n). 
And we have the following asymptotic convergence theorem: 
                     ),0()( 22σθ mNUn
L
n →−                              (3.1.3) 
Here nmUVar n /)(
22σ→  for large n. 
The important extension to k-sample problems for k>1 has been made by Lehmann 
(1951) [7]. The basic ideas are contained in the 3-sample case which is discussed here. Here P is 
a family of probability measures, (F, G, H). 
Consider independent samples, 
1
,...,1 nXX  from F(x), 2,...,1 nYY  from G(y) and 
3
,...,1 nZZ  from H(z). Let ),...,,,...,,,...,( 321 111 mmm zzyyxxh  be a kernel, and let P be the set of all 
vectors such that the expectation 
      ),...,,,...,,,...,(),,(
321 111,, mmmHGF
ZZYYXXhEHGF == θθ                    (3.1.4) 
is finite. We may assume without loss of generality that h is symmetric under independent 
permutations of 
21
,...,,,..., 11 mm yyxx  and 3,...,, 1 mzz . The corresponding U-statistic is  
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where the sum is over all 
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 sets of subscripts such that 
11 1
...1 nii m ≤<<≤ , 21 2...1 njj m ≤<<≤  and 31 3...1 nkk m ≤<<≤ . Again, it is clear that U is 
an unbiased estimate of θ . 
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According to one sample U-statistic asymptotic theorem, we have the following. Let 
  ),,...,,,...,,,...,,,...,,,...,,,...,([
321 111111
2
mkkmjjmiiijk ZZZZYYYYXXXXhCov +++=σ  
            )]',...,',,...,,',...,',,...,,',...,',,...,(
321 111111 mkkmjjmii
ZZZZYYYYXXXXh +++                                         
(3.1,6) 
 
where the X’s, Y’s and Z’s are independently distributed according to F, G and H  
respectively. 
For P∈P, 
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Moreover, if 2 ,, 321 mmmσ  is finite, and if )1,0(/ 11 ∈→ pNn , )1,0(/ 22 ∈→ pNn  as  
∞→++= )( 321 nnnN , then  
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3.2 Inference of VUS using U-statistics 
Apply the 3-sample U-statistics in section 3.1 to the VUS, we have the following 
theorem: 
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Theorem 3. Let 
321 ,, nnn
U  be the estimate of the VUS and VUS be the real value. 321 ,, nnn  are 
the sample size of each class. )1,0(/ 11 ∈→ aNn , )1,0(/ 22 ∈→ aNn  and 213 1 aaa −−=  as 
∞→++= )( 321 nnnN . Then when sample size is large enough, 
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Lemma 1:  Let *NT , N=1,2,… be a sequence of random variables, the distribution of which 
tend to a limit distribution L, and let 
NT  be another sequence satisfying 0)(
2* →− NN TTE . 
Then, the distribution of NT  also trends to L. 
Proof 
Let NNN TTR −=
* . Then 0
P
NR → . Therefore, NT  and 
*
NT  have the same limit distribution. 
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This completes the proof of lemma 2. 
 
Proof of theorem 3 
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When sample size is small, we use (3.2.2) to estimate 2σ : 
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3.3 Empirical likelihood method  
Empirical likelihood (EL) (Owen, 1990, 2001) [8] is a popular non-parametric method 
traditionally used for providing confidence intervals for means. The EL method has many 
advantages over other non-parametric methods. For example, it has better small sample 
performance than approaches based on normal approximation; empirical likelihood based 
confidence regions are range preserving and transformation respecting; the regularity conditions 
for empirical likelihood based methods are weak and natural. However, the empirical likelihood 
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method has not been used widely in the study of accuracy of diagnostic tests. Qin and Zhou 
(2005) [9] proposed empirical likelihood based confidence intervals for the area under the ROC 
curve. In this section, we are going to use the idea of empirical likelihood method to construct 
EL-based confidence intervals for the proposed VUS. 
 
3.4 Inference of VUS using multi-sample empirical likelihood method 
As the definition, 
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Notice 0)ˆ( =−θθE . The empirical likelihood ratio can be expressed as 
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where θθ −= ),,()( 321 kjiijk XXXhH  
Then, the corresponding empirical log-likelihood ratio for VUS is )(log2)( θθ Rl −= .        
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Theorem 4. If θ  is the true value of VUS, then the limit distribution of empirical log-likelihood 
ratio )(θl  is a chi-square distribution with one degree of freedom. That is 
                          21)( χθ →Ll                                                (3.4.3) 
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Using Lagrange multiplier we find that  
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The proof of Theorem 4 is thus complete. 
 
3.5 Empirical likelihood confidence interval construction 
Notice that, in order to find the lower bound and upper bound of empirical likelihood 
based confidence interval for VUS, we have to solve 2321 +++ nnn  nonlinear equations, they 
are, 
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Now, we have 2321 +++ nnn  parameters ( θλ,,,...,,,...,,,... 321 331221111 nnn uuuuuu ). 
The lower and upper limit of EL confidence interval will be the two solutions of θ . In order to 
find the numerical solutions of this equation system, an algorithm is proposed here: 
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Step II: Solve nonlinear equations (3.4.7) and (3.5.15) given initial ),0(),( 000 θθλ = . 
Step III: Substitute the solutions of Step II into (3.4.4)-(3.4.6) to upgrade 1u , 2u  and 3u . Then 
go to Step II to solve (3.4.7) and (3.5.15) using the solution of Step II as initial value until 
converge. 
According to the EL theory, given large initial value of 0θ , the final solution of θ  will 
converge to EL upper limit and given small initial value of 0θ , the final solution of θ  will 
converge to EL lower limit. 
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CHAPTER 4 
VUS for any number of classes 
 
It is straightforward to generalize new proposed VUS to k-class case as follows: Let the k 
classes be “ 1L ”, “ 2L ” … “ kL ”. Also, let iX  be the classifier in k populations with i=1, 2…k 
representing kLLL ,...,, 21  respectively. If we use 121 ,...,, −kCCC  as the cutoff points, then we have 
similar table as 3-class case: 
 
Table 4.1 Multi-class diagnosis table 
                 Actual Diseased Status  
Level-1 Level-2    … … Level-k 
Level-1     1h      12F     … …    kF1  
Level-2     21F       2h     … …    kF2  
  … …    … …    … …    … …   … … 
    
 
 
 
 
    Test 
Level-k    1kF      2kF     … …     kh  
 
Similar to 3-class case, we have k-1 sensitivities and k-1 specificities, we denote 
)|( irealidiagnosedPySensitivit i ≤≤=  i=1,2,…,k-1                             (4.1) 
)|( irealidiagnosedPySpecificit i >>=  i=1,2,…,k-1                             (4.2) 
35 
 
Assume the population ratio for the k-level is 
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 For sensitivity, 
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Here, 1,2211,111 ,...,,,... −− kk UUUU  are the kernels of 1,2211,111 ,...,,,... −− kk WWWW  separately. 
Similar to 3-class case, we can define and express VUS as  
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Theorem 4. With the set up as stated above, the estimated VUS is 
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            (4.14) 
and },...,1|{ iij njX = , i=1, 2,…,k are k random samples from kLLL ,...,, 21  population, 
respectively. 
 
Proof,  
The proof of this theorem is similar to 3-class case but the procedure is massy. We sketch 
the proof as follows:. 
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Denote 1,2 −kA  by ),...,,( 21 kXXXK . Then,  
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When kj ii =  then we have 
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This is the same as we find in chapter 2. 
When k=4,  
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U-statistics is also available to do inference, but the calculation of asymptotic variance is 
massy when the number of class levels is large. So we skip this part in this dissertation. 
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CHAPTER 5 
Simulation study 
 
5.1 Calculation for theoretical VUS value 
From corollary2 in chapter2 we have derived  
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where )( 321 XXXPVUS NY ≤≤= , ),( 32132 XXXPAUC ≤=− ,  
),( 32112 XXXPAUC ≤=−  and )( 312 XXPAUC ≤=−  
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Gaussian Quadrature method is used to calculate numerical integration for our simulation 
study. 
In numerical analysis, a quadrature rule is an approximation of the definite integral of 
function, usually stated as a weighted sum of function values at specified points within the 
domain of integration. An n-point Gaussian quadrature rule, named after Carl Friedrich Gauss, is 
a quadrature rule constructed to yield an exact result for polynomials of degree 2n-1 or less by a 
suitable choice of the points 
ix  and weights iw  for i=1,…,n. The domain of integration for 
such a rule is conventionally take as [-1, 1], so the rule is stated as 
                     ∫ ∑
−
=
≈
1
1
1
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n
i
ii xfwdxxf                           (5.1.6) 
It can be shown (see Press, et al., or Stoer and Bulirsch) that the evaluation points are just 
the roots of a polynomial belonging to a class of orthogonal polynomials. 
For the integration problem stated above, the associated polynomials are Legendre 
polynomials, )(xPn . With the 
thn  polynomial normalized to give 1)( =xPn , the 
thi  Gauss 
node, ix , is the 
th
i  root of )(xPn , its weight is given by (Abramowitz & Stegun 1972, p. 887) 
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Some low-order rules for solving the integration problem are listed in Table 5.1. 
An integral over [a, b] must be changed into an integral over [-1,1] before applying the 
Gaussian quadrature rule. This change of interval can be done in the following way: 
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Table 5.1 Gaussian quadrature points and weights 
Number of points, n       Points, ix       Weights iw  
          1          0          2 
          2        3/1±           1 
         0         8/9           3 
5/3±          5/9 
    7/5/623 −±        
36
3018 +
 
          4 
    7/5/623 +±        
36
3018 −
 
0       128/225 
7/1025
3
1
−±  
900
7013322 +
 
 
          5 
7/1025
3
1
+±       
900
7013322 −
 
 
An integral over [a, b] must be changed into an integral over [-1,1] before applying the 
Gaussian quadrature rule. This change of interval can be done in the following way: 
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 After applying the Gaussian quadrature rule, the following approximation is obtained: 
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Gaussian quadrature method is used to calculate definite integral in limited domain. But 
the integral domain we try to calculate is ),( +∞−∞ . However, the functions we integrate 
converge to 0 when x goes to ∞−  and ∞+ . Then, when we take small enough lower limit and 
large enough upper limit, the integral will be close to true value. 
In order to make the theoretical value of VUS more accurate, we select five points for the 
Gaussian quadrature in this dissertation. 
 
5.2 VUS mapping and theoretical value selection. 
In this section, we try to compare the performance of different inference methods for 
different VUS values. But the maximum and minimum values of VUS are much smaller than 
that of the AUC because they are measures from different dimension space. In order to make a 
comparative numbers, proper transformation from VUS to AUC is necessary. Here we propose 
two mapping methods.  
The most straightforward mapping is linear mapping. The formula is as follow:  
MinMax
Min
MinMax
Min
AUCAUC
AUCAUC
VUSVUS
VUSVUS
−
−
=
−
−
                        (5.2.1) 
Here the maximum and minimum value of AUC is 1 and 0.5, and the maximum, and the 
minimum values of VUS are derived in corollary 2 in chapter 2. 
When d=3, VUS is the volume from 2(d-1)=4 dimensional space, and AUC is from a two 
dimensional space. Hence, it is more reasonable to modify linear mapping to quadratic mapping 
for d=3. Since the unit for dimension 4 is square of the dimension 2, quadratic transformation 
might be more reasonable. Hence, before mapping VUS to AUC, taking square root to VUS can 
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balance the dimension difference between VUS and AUC. Then the transformation formula is as 
follow: 
             
MinMax
Min
MinMax
Min
AUCAUC
AUCAUC
VUSVUS
VUSVUS
−
−
=
−
−
 (5.2.2) 
We can also illustrate the above mapping methods by the graph below: 
 
Figure 5.1 VUS transformation 
   
In this simulation studies, we properly select the distribution of three classes such that the 
value of VUS is “small”, “median” and “large” separately. Since it is difficult to get the fix VUS 
by selection the parameters of distribution, we only choose distributions such that the AUC 
mapping from small VUS is around 0.65, the AUC mapping from median VUS is around 0.75 
and the AUC mapping from large VUS is around 0.9. For each level of VUS, two kinds of 
locations are selected. For normal case, one kind is the mean of “suspicious” is in the middle of 
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“Disease” and “Benign”. And another kind is mean of “suspicious” is bias to “Benign”. For 
gamma case, one kind is the beta of “suspicious” is in the middle of “Disease” and “Benign”. 
And another kind is beta of “suspicious” is bias to “Benign”.  
The population proportion we select in this simulation studies is 2:1:2. 
Our simulation studies cover the cases of normal distribution and gamma distribution and 
the VUS values table and graphs are list in Table 5.2-Table 5.3 and Figure 5.2- Figure 5.3. 
 
5.3 Simulation method and conclusion 
Our simulation studies cover the cases of normal distribution and gamma distribution for 
X1, X2, X3, with sample sizes 40 (small sample) and 100 (large sample). In total, 300 confidence 
intervals were constructed for each simulation. For normal distribution, we simulated with 
various values of ),,( 321 µµµ  and ),,( 321 σσσ . Similarly, various values of parameters for 
gamma distribution are used. Three methods of constructing confidence intervals are used for 
comparison purpose. First two are the proposed U-statistic method and empirical likelihood 
method, while the other one is the bootstrap method. Using 95% confidence interval, we 
calculate the coverage rate of the theoretical VUS, which is computed using Gaussian quadrature 
to do the integrations. From Table 5.4 and Table 5.5, both normal and gamma distributions 
behave about the same in terms of the coverage rate. Except for the high volume and small 
sample case, the U-statistics method seems outperform the bootstrap case for the coverage rate. 
This indicates that the method of U-statistic indeed has its merit. The empirical likelihood has 
significantly shorter interval length than U-statistic and Bootstrap method. However, they always 
seems to have the least coverage probabilities. 
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Table 5.2 Theoretical VUS for normal distribution 
 
2:1:2:: 321 =aaa                         ),,( 321 µµµ  
Theoretical VUS      (1, 2, 3)      (1, 1.5, 3) 
 (0.5, 0.5, 0.5) 0.4124169  
(0.945953519*) 
(0.95657799**) 
      0.3913009 
(0.910320269*) 
(0.927020809**) 
(1.25,1.25, 1.25)   0.3029789 
(0.761276894*) 
(0.793745033**) 
      0.2980189 
(0.752906894*) 
(0.785716899**) 
 
 
 
   ),,( 321 σσσ  
     (3, 3, 3)   0.2158898 
(0.614314038*) 
(0.64149882**) 
   0.2152842 
(0.613292088*) 
(0.640341574**) 
                   * linear mapping                 ** quadratic mapping 
 
Figure 5.2 Population density for three normal distributions 
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Table 5.3 Theoretical VUS for gamma distribution 
 
                                        3321 === ααα  
  Beta Theoretical VUS    Beta Theoretical VUS 
 (1, 4, 7)    0.370911 
(0.875912313*) 
(0.897713108**) 
 (1, 5, 7)            0.3539129 
(0.847228019*) 
(0.872658959**) 
 (1, 2, 3)    0.3131569 
(0.778452269*) 
(0.810015675**) 
(1,2.5,3)       0.3026353 
(0.760697069*) 
(0.793191019**) 
 
 
    
 
),,( 321 βββ  
(1,1.25,1.5)   0.2128605 
(0.609202094*) 
(0.635693736**) 
(1,1.3,1.5)   0.2125777 
(0.608724869*) 
(0.635149701**) 
                 * linear mapping                 ** quadratic mapping 
 
Figure 5.3 Population density for three gamma distributions 
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Table 5.4 Simulation for normal distribution 
 
Sample size: (16, 8, 16) Sample size: (40, 20, 40) Parameter 
),,( 321 µµµ  
),,( 321 σσσ  
Method 
Coverage  
probability 
Interval 
Length 
Coverage  
probability 
Interval 
Length 
U-Statistic 92.67% 0.0629859 93.33% 0.0412557 
Bootstrap 93.33% 0.0694444 93.00% 0.0358333 
(1, 2, 3) 
(0.5, 0.5, 0.5) 
EL 92.00% 0.0625617 92.67% 0.0314602 
U-Statistic 91.67% 0.0681728 94.33% 0.0545882 
Bootstrap 91.00% 0.0806944 92.67% 0.0555417 
(1, 1.5, 3) 
(0.5, 0.5, 0.5) 
EL 91.67% 0.0700987 92.33% 0.0471504 
U-Statistic 96.00% 0.1167010 95.00% 0.1042770 
Bootstrap 94.67% 0.1112196 93.33% 0.0954097 
(1, 2, 3) 
(1.25, 1.25, 1.25) 
EL 91.67% 0.0984592 93.00% 0.0892522 
U-Statistic 94.00% 0.1191885 95.33% 0.0963394 
Bootstrap 94.00% 0.1259592 93.00% 0.0801250 
(1, 1.5, 3) 
(1.25, 1.25, 1.25) 
EL 92.00% 0.0989351 92.67% 0.0774620 
U-Statistic 94.00% 0.1341069 95.33% 0.1108490 
Bootstrap 90.00% 0.1310764 94.33% 0.0936181 
(1, 2, 3) 
(3, 3, 3) 
EL 91.33% 0.1102676 92.67% 0.0869033 
U-Statistic 92.67% 0.1554159 94.67% 0.1274900 
Bootstrap 91.67% 0.1489800 91.33% 0.0978056 
(1, 1.5, 3) 
(3, 3, 3) 
EL 91.67% 0.1187315 92.67% 0.0853628 
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Table 5.5 Simulation for gamma distribution 
 
Sample size: (16, 8, 16) Sample size: (40, 20, 40) Parameter 
),,( 321 ααα  
),,( 321 βββ  
Method 
Coverage  
probability 
Interval 
Length 
Coverage  
probability 
Interval 
Length 
U-Statistic 91.00% 0.0715118 94.00% 0.0426619 
Bootstrap 93.33% 0.0876389 93.33% 0.0465625 
(3, 3, 3) 
(1, 4, 7) 
EL 90.67% 0.0706879 91.67% 0.0401577 
U-Statistic 91.67% 0.1089553 93.33% 0.0482550 
Bootstrap 92.00% 0.1158681 93.33% 0.0499583 
(3, 3, 3) 
(1, 5, 7) 
EL 91.33% 0.0867319 92.67% 0.0427180 
U-Statistic 96.00% 0.1254224 95.33% 0.0698427 
Bootstrap 94.00% 0.1379861 96.67% 0.0745069 
(3, 3, 3) 
(1, 2, 3) 
EL 92.00% 0.1138948 93.00% 0.0626753 
U-Statistic 95.00% 0.1013915 95.33% 0.0711492 
Bootstrap 93.00% 0.1156337 92.67% 0.0766806 
(3, 3, 3) 
(1, 1.5, 3) 
EL 91.67% 0.0959068 92.67% 0.0699184 
U-Statistic 94.33% 0.1334723 94.67% 0.0894067 
Bootstrap 92.67% 0.1402648 94.00% 0.0949444 
(3, 3, 3) 
(1, 1.25, 1.5) 
EL 91.33% 0.1175874 92.00% 0.0831169 
U-Statistic 95.33% 0.1530327 94.33% 0.0931584 
Bootstrap 93.00% 0.1425781 94.67% 0.0992847 
(3, 3, 3) 
(1, 1.3, 1.5) 
EL 91.33% 0.1289447 92.33% 0.0884236 
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CHAPTER 6 
Introduction of a study on intellectual outcome  
in pediatric brain-tumor patients 
 
6.1 Background: 
Intracranial tumors are the second most common neoplasm occurring in children under 15 
years of age with an estimated incidence of 1200 cases per year in the United States (Cohen & 
Duffner, 1984). While the absolute number of children with intracranial tumors is small, 
improved treatment outcomes (Finlay, Uteg, & Giese, 1987) have resulted in a need for increased 
attention to the quality of survival for these patients. The critical location of these neoplasms and 
the risk to cerebral integrity as a result of standard treatment that may include surgery, high-dose 
central nervous system (CNS) radiation, and/or neurotoxic chemotherapeutic agents put such 
children at greater risk for suboptimal behavioral, emotional, and cognitive outcomes as 
compared to children with other malignancies (Danoff Cowchock, Marquette, Mulgrew, & 
Kramer, 1982; Duffner, Cohen, & Thomas,1983; Hirsch, Renier, 1979; Le-Baron, Zeltzer, Scott, 
& Marlin, 1988).  
Investigators are seeking a better understanding of the degree and type of short- and long-
term neuropsychological impairment as well as important disease treatment, and patient risk 
factors related to this morbidity. Such information would be critical throughout treatment so that 
children and their families could be informed regarding anticipated outcomes and the 
development of effective rehabilitation programs could be facilitated. These data might also 
permit modification of treatment protocols to reduce subsequent morbidity without sacrificing 
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efficacy (Halberg et al., 1990). In addition, these children provide an opportunity to learn more 
about the long-term neuropsychological sequelae for a host of CNS trauma related to the 
neoplasms and their treatment. 
The Stanford-Binet Intelligence Scale-Fourth Edition (SB-IV) [41] is a widely 
standardized measurement of intellectual functioning appropriate for individuals aged 2-23 years. 
Administration of the SB-IV yields estimates of overall intellectual functioning, verbal 
reasoning, quantitative reasoning, abstract visual reasoning, and short-term memory abilities. The 
indices of the SB-IV have demonstrated good reliability, internal consistency, and criterion-
related validity across studies. In this dissertation paper, SB-IV Test is taken for each patient in 
several time points after diagnosis.  Besides composite IQ, other four test scores (STB Verbal 
Reasoning SAS score, STB Abstract/Visual Reasoning SAS score, STB Quantitative Reasoning 
SAS score, STB Short-Term Memory SAS score) are also considered as response variables so 
that we can obtain more details about how the risk factors impact the performance of pediatric 
brain-tumor patients in tasks of intellectual functioning. 
The children who have undergone treatment for brain tumors which have direct impact on 
crucial brain structures underlying behavior and may be more likely to exhibit cognitive 
difficulties than their peers. Although studies have found that survivors are at risk for a variety of 
physical, medical, cognitive, and/or psychosocial late effects, the particular risk factors having an 
impact on children’s psychosocial and behavioral functioning are not fully understood. These late 
effects may be directly related to the type of treatment (surgery, chemotherapy, and/or radiation), 
characteristics of the disease (tumor size and type), and individual demographic factors, such as 
age and socioeconomic status.  
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For treatment factors, two types of measurements are taken into account and compared in 
this study. If the patients have taken radiation therapy and/or chemotherapy is considered as first 
type of treatment factor. Radiation therapy and chemotherapy are generally used as secondary or 
adjuvant treatments for tumors that cannot be managed using only surgery. However, radiation 
and chemotherapy may be used without surgery if the tumor is inoperable. Radiation therapy uses 
high-energy x-rays or other types of ionizing radiation to stop cancer cells from dividing. 
Because the developing brain of a child is very sensitive to radiation therapy, it is deliberately 
limited. Chemotherapy required for the more aggressive tumors uses chemicals (drugs) that have 
a toxic effect on tumor cells as they divide. Survival rates of children with certain types of brain 
tumors have been significantly improved by the treatment of radiation therapy and chemotherapy. 
The Neurological Predictor Scale (NPS) [16] was used to look at multiple factors related 
to outcome. NPS was developed to address the needs of researchers in the field of pediatric 
neuro-oncology. It is a nonratio, ordinal scale that can be used to rate patients across 4 primary 
domains including tumor-related conditions, operative events, radiation treatment, and 
chemotherapy. Participants’ ratings are summed across the 4 domains to yield a total score. The 
Neurological Predictor Scale can be calculated from a brief review of medical record data.  
 
6.2 Source of data: 
The data for this study comes from a longitudinal study conducted by Robin Morris of 
Georgia State University over 15 years ago. Tricia King in collaboration with Robin Morris and 
other researchers are evaluating the survivors of childhood brain tumors from the original 
longitudinal study when began at the time when children were diagnosed and treated. Drs. Tricia 
King and Robin Morris (Department of Psychology) and along with Dr. Yu-Sheng Hsu 
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(Mathematics and Statistics Department) are conducting studies to identify the predictors of 
longitudinal data such as the SB-IV test score. We analyzed change in five SB-IV test scores over 
time in these children. 
Between 1985 and 1996, 153 patients participated in the longitudinal study and 95 out 
153 patients are involved in this study whose information is complete and number of 
observations is at least two. The total number of observations among this 95 patients is 488 in 
which 478 STB Verbal Reasoning SAS scores, 476 STB Abstract/Visual Reasoning SAS scores, 
478 STB Quantitative Reasoning SAS scores, 486 STB Short-Term Memory SAS scores and 486 
STB Composite IQ scores are recorded. The patients’ data also includes date of birth of the 
participant, gender, socioeconomic status, treatments (Radiation and/or Chemotherapy) the 
patient undertook, Neurological Predictor Scale the patient had, date of the diagnosis, and date of 
taking SB-IV test. The age of diagnosis of those 95 patients is ranged from 0.42 to 16.67 years 
old. The amount of time between diagnosis and SB-IV test in years is ranged from 0 to 15.92. 
The Neurological Predictor Scale is ranged from 0 to 10. The socioeconomic status is ranged 
from 1 to 5. The range of observation per patient is from 2 to 11.  
The potentially predictive variables included in this study are gender, age at diagnosis, 
Socioeconomic Status Class (SES), chemotherapy, radiation, time since treatment and 
Neurological Predictor Scale (NPS). A family's socioeconomic status is based on family income, 
parental education level, and parental occupation. There are five levels for SES class in which 
class1 is the highest level and class 5 is the lowest level. Neurological Predictor Scale (NPS) is a 
nonratio, ordinal scale. It is a sum of patients’ rated scores across 4 domains which are tumor-
related conditions, operative events, radiation treatment, and chemotherapy [16].  
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Table 6.1 Descriptive table of treatments, gender, and SES classes 
Patients Observations 
Variables 
With without with  Without 
Radiation 56 39 282 206 
Chemotherapy 26 69 144 344 
  Patients Observations 
Male 51 276 
Female  44 212 
Age<=7 years 
old 55 323 
Age>7 years 
old 40 165 
 
 Patients Observations 
1 2 3 4 5 1 2 3 4 5 
SES classes 
10 20 27 26 12 51 126 134 124 53 
 
Table 6.2 Descriptive table of SB-IV scores, NPS, age at diagnosis and time 
Variables Mean Standard Deviation Range 
STB Verbal Reasoning 
SAS scores 96.5188285 16.0424836 51 to 141 
STB Abstract/Visual 
Reasoning SAS scores 94.8634454 18.7858919 38 to 191 
STB Quantitative 
Reasoning SAS scores 93.0355649 16.4850733 56 to 136 
STB Short-Term Memory 
SAS scores 92.9300412 18.6529687 50 to 153 
STB Composite IQ scores 93.2489712 17.339834 50 to 140 
Neurological Predictor 
Scale 5.82786885 2.12714005 0 to 10 
Age at diagnosis (years) 6.18739754 3.60554068 0.42 to 16.67 
Time(years between 
diagnosis and SB-IV test) 3.69686475 3.10603926 0 to 15.92 
 
The data consisted of 488 records on 95 individuals. The frequency distribution of the 
number of time points is seen in Table 6.3. The five SB-IV scores on 95 children are displayed 
graphically in Fig. 6.1 - Fig. 6.5.  
56 
 
Table 6.3 Time point count distribution 
Number of Time 
Points 
Frequency Percent Cumulative Percent 
2 15 15.79 15.79 
3 12 12.63 28.42 
4 18 18.95 47.37 
More than 3 50 52.53 100.00 
 
 
Figure 6.1 Individual Verbal Reasoning SAS score trajectories 
 
Figure 6.2 Individual Abstract/Visual Reasoning SAS score trajectories 
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Figure 6.3 Individual Quantitative Reasoning SAS score trajectories 
 
 
    
Figure 6.4 Individual Short-Term Memory SAS score trajectories 
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Figure 6.5 Individual composite IQ score trajectories 
6.3 Method of analysis 
In order to analyze change over time in psychological studies, there are numerous 
traditional methods that can be applied. These include the mixed model analysis of variance 
(ANOVA) and the multivariate approach to repeated measures, the analysis of covariance 
(ANCOVA) or residualized change analysis, and the analysis of covariance with reliability 
correction (ANCOVARC).  
In this study, we will use hierarchical linear individual growth model and Gompertz 
based growth model to analyze the changes over time in SB-IV test score data. Much study 
shows that it is both possible and desirable to model change at the individual level [17]. The 
hierarchical linear individual growth model is a relative new statistical technique now widely 
used to examine the unique trajectories of individuals and groups in repeated measures data. And 
in this dissertation, we also propose a Gompertz based growth model. It is a nonlinear individual 
growth model, which turns out to be a better model than the hierarchical models for most of our 
response varibles using PRESS and VUS as criteria. 
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CHAPTER 7 
Methodology and data analysis 
 
In this chapter, the individual growth models are presented. Since repeated SB-IV test 
measurements taken on each child were obtained over time, hierarchical models were used for 
the analysis of change. To explain the change over time of five SB-IV test scores, two sets of 
explanatory variables were considered. One set includes Years between date of diagnosis and 
date of test (Time), Gender, Age group at diagnosis (Age group is define to be 1 if patient’s age 
at diagnosis is greater than 7, otherwise, it is defined to be 0), SES classes, Treatments (radiation 
and chemotherapy), and potential interactions of these variables. The other model consists of 
Years between date of diagnosis and date of test (Time), Gender, Age group at diagnosis, SES 
classes, Neurological Predictor Scale (NPS), and potential interactions of these variables. The 
patients are assumed to be random and other variables are fixed effects in the model. In this 
chapter, both hierarchical linear model and Gompertz based nonlinear model are applied to the 
dataset and PRESS and VUS are selected as criteria to compare the performance of the models. 
 
7.1 The hierarchical linear model (HLM) 
Longitudinal studies sometimes known as repeated measures are encountered in a wide 
variety of disciplines. Longitudinal data is the union of cross-sectional and time series data. The 
balanced design in longitudinal data analysis assumes a complete data set with an equal number 
of measurements over time for each subject, while the unbalanced design has incomplete data 
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without equal time intervals or time points for each subject [18,19]. Literature shows that 
hierarchical linear model (HLM) can be employed in longitudinal data analysis.  
When HLM is applied to longitudinal data analysis, the level 1 units are the repeated 
measures for each subject and the level 2 units consist of subjects. The repeated measures are 
conceived as nested within each subject. The level 1 model includes time or/and quadratic time 
as the predictor(s). The within-subject model is: 
ititiiit eTY ++= 10 pipi              (7.1.1) 
                    or  ititiitiiit eTTY +++=
2
210 pipipi                          (7.1.2) 
By convention, within person effects are indicated by the symbolpi . itY  represents the 
outcome for individual i  measured at time t . itT  represents time from the base line 
assessment for person i . For model 1, the slope i1pi  is the linear growth rate for the 
thi  person 
and the intercept, i0pi , represents the expected outcome of the person at baseline, also called 
initial status. For model 2, i1pi  and i2pi  are the coefficients of the first and second order of itT  
respectively. The within-person residuals, ite , are assumed ),0(
2σN . 
At level 2, the goal is to investigate variations in the estimates of the coefficients in level 
1 model. The between-subjects models are: 
ippii
iippii
iippii
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βββpi
βββpi
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           (7.1.3) 
Accordingly, 1000 , ββ  and 20β  represent the expected baseline and slope, respectively. 
The coefficients for the predictors indicate how much these expected values increase or decrease. 
The random effects at level 2 are assumed to be 
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        (7.1.4) 
Substitute Equation (7.1.3) into (7.1.1) or (7.1.2), we can reduce the 2-level model. 
The hierarchical linear model extends the general linear model by allowing a more 
flexible specification of the covariance matrix of error. It allows for both correlation and 
heterogeneous variances. 
The hierarchical linear model can be written as the form of mixed model: 
 εγβ ++= ZXy                                       (7.1.5) 
Where y denotes the vector of observed values, X is the known matrix of explanatory variables, 
β  is the unknown fixed-effect parameter vector, Z is the known design matrix of random effects, 
γ  is the unknown random parameter and ε  is the unobserved vector of independent and 
identically distributed Gaussian random errors.  
A key assumption in the foregoing analysis is that γ  and ε  are normally distributed 
with 
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                                  (7.1.6) 
The variance of y is, therefore, RZGZV += '2σ . Here the structure of G is specified in 
(7.1.4) and (7.1.6) and nIR =  
After those assumptions, observed responses are treated as a realization of a multivariate 
Gaussian random vector, Y , with  
         ),(~ 2VXMVNY σβ     (7.1.7) 
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Under the multivariate Gaussian assumption, the weighted least-square estimate βˆ  is the 
maximum likelihood estimator for β  given V , i.e., 
           yVXXVXV 111 ')'()(ˆ −−−=β  (7.1.8) 
Two likelihood-based methods: maximum likelihood (ML) and restricted/residual 
maximum likelihood (REML) can be implemented and the corresponding estimates of 2σ  are  
            ML: NVRSSV /)()(ˆ 2 =σ  (7.1.9) 
         REML:  )/()()(ˆ 2 pNVRSSV −=σ  (7.1.10) 
where N  is total sample size, p  is the number of elements of β  and  
           ))(ˆ())'(ˆ()( 1 VXyVVXyVRSS ββ −−= −  (7.1.11) 
Substitute conditional estimates of β  and 2σ  into log-likelihood functions, we can 
construct log-likelihood functions: 
        ML: )2log(
2
)(
2
1
||log
2
1
)( pi
N
VRSSVVl −−−=  (7.1.12) 
     REML: )2log(
2
|'|log
2
1
)(
2
1
||log
2
1
)( 1 pi
pN
XVXVRSSVVlR
−
−−−−=
− (7.1.13) 
Newton-Raphson algorithm is applied to maximize the log-likelihood function for 
estimate of V . In this dissertation, we use ML method to do estimation and inference. 
 
7.2 Gompertz based hierarchical model 
7.2.1 Gompertz nonlinear model 
A Gompertz curve or Gompertz function, named after Benjamin Gompertz, is a sigmoid 
function. It is a commonly used mathematical model for a time series, where growth is slowest at 
the start and end of a time period.  
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ctbe
aety =)(                                   (7.2.1.1) 
where a is the upper asymptote, c is the growth rate, and b, c are negative numbers. 
In the sixties, Laird [20] for the first time successfully used the Gompertz curve to fit data 
of growth of tumors. In fact, tumors are cellular populations growing in a confined space where 
the availability of nutrients is limited. Denoting the tumor size as )(tX  it is useful to write the 
Gompertz Curve as follows: 






−= )exp()
)0(
log(exp)( t
K
y
Kty α                  (7.2.1.2) 
where: )0(y  is the tumor size at the starting observation time; K  is the carrying capacity, i.e. 
the maximum size that can be reached with the available nutrients. In fact it is: Kty
t
=
+∞→
)(lim  
independently on 0)0( >y . Note that, in absence of therapies etc. usually it is Ky <)0( , 
whereas, in presence of therapies, it may be Ky >)0( ; α is a constant related to the proliferative 
ability of the cells.  
It is easy to verify that the dynamics of )(ty  is governed by the Gompertz differential 
equation:  
                              )()
)(
log()(' ty
ty
K
ty α=                        (7.1.1.3) 
Furthermore, )(' ty  can be expressed as: )())(()(' tytyFty = , where 0)(' ≤yF  and 
)(yF  is the instantaneous proliferation rate of the cellular population, whose decreasing nature 
is due to the competition for the nutrients due to the increase of the cellular population, similarly 
to the logistic growth rate. However, there is a fundamental difference: in the logistic case the 
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proliferation rate for small cellular population is finite: +∞<=⇒−= αα υ )0())(1()( F
K
y
yF , 
whereas in the Gompertz case the proliferation rate is unbounded:     
                  +∞==
+→+→
)log(lim)(lim
00 y
K
yF
yy
α  
As noticed by Steel [21] and by Wheldon [22] the proliferation rate of the cellular 
population is ultimately bounded by the cell division time. Thus, this might be an evidence that 
the Gompertz equation is not good to model the growth of small tumors. Moreover, more 
recently it has been noticed [23] that, including the interaction with immune system, Gompertz 
and other laws characterized by unbounded )0(F  would preclude the possibility of immune 
surveillance. 
 
7.2.2 Gompertz based hierarchical model 
In order to employ Gompertz function into longitudinal data analysis, we reparameterize 
the function and generalize it to hierarchical nonlinear model. Take log on both side of (7.2.1.1) 
and make simple reparameterization we can get log-Gompertz function: 
)exp()(log 210 tty ααα −−= . Similar to hierarchical linear model, we treat it as the 1 level 
model, i.e., 
                
itiiiit etY +−−= )exp(log 210 ααα                  (7.2.2.1) 
At level 2, the goal is to investigate variations in the estimates of coefficients in level 1 
model. The between-subjects models are: 
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      or    
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The random effects at level 2 are assumed to be 
            ),0(~ 2000 σNu i                              (7.2.2.4) 
or 
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Substitute Equation (7.2.2.2) into (7.2.2.1) or (7.2.2.3) into (7.2.2.1), we can reduce the 2-
level model. 
The number of random effects can be selected arbitrary which depends on the criterion 
we select. In most of cases, one random effect can yield better weighted adjusted PRESS and 
VUS. In this dissertation paper, we select two-random-effect model only for short-term memory 
SAS score and for all other responses, we use one-random-effect model. 
The Gompertz based hierarchical nonlinear model can be written as the form of nonlinear 
marginal mixed model: 
 εγβ ++= Zy )(log f                                (7.2.2.6) 
Where y denotes the vector of observed values, f is the known nonlinear vector function, β  is 
the unknown fixed-effect parameter vector, Z is the known design matrix of random effects, γ  
is the unknown multi-normal random parameter with mean 0 and covariance matrix D2σ , and 
ε  is the unobserved vector of independent and identically distributed Gaussian random errors 
with variance 2σ .  
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The key characteristic of this model is that the random effects enter the model in a linear 
fashion. This model is called marginal because the marginal expected value of the response 
variable, iylog  can be expressed in closed-form as a function of the population parameter β , 
namely, )()(log βii fyE = . Consequently, even a straightforward Nonlinear Least Squares 
(NLS), which minimizes the sum of squares 
                   ∑
=
−
m
i
ii fy
1
2||)(log|| β ,                        (7.2.2.7) 
produces a consistent estimator of β  when ∞→m  and }{ in  are bounded.  
Since γ  and ε  are normally distributed, the marginal model (7.2.2.6) can be written 
compactly as 
             ))'(),((~log 2 iiii DZZIfNy +σβ , i=1,…,m                      (7.2.2.8) 
with the log-likelihood function, up to a constant term )2ln(
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(7.2.2.9) 
where ))(,,( 2 Dvecσβθ =  is the complete vector of parameters. The information matrix for the 
nonlinear model for θ  has a block-diagonal form, 
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is the expected Hessian (information) matrix for variance parameters, and  
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    'iii DZZIV += , ')'(
111
iiiii ZZZDZIV
−−
− +−= , ')'( 1 DDDD −+ =           (7.2.2.12) 
        111 ))'((')'( −−− +=+= DZZZDZZIZR iiiiiii .             (7.2.2.13) 
Note that the right-hand sides are valid if the matrices D and ii ZZ '  are invertible. The 
asymptotic covariance matrix for θ  is the inverse of IF . 
We may obtain a variance-profile log-likelihood, 
}||ln))((log))'((logln{5.0),( 1 ∑∑ +−−−= − iiiiiip VfyVfyNDl βββ       (7.2.2.14) 
because when β  and D are held fixed, the log-likelihood maximum is attained at 
))((log))'((log 112 ββσ iiiii fyVfyN −−= −− ∑ . Since the information matrix, IF , has a block-
diagonal form, we may maximize l  over β  and the variance parameters separately. Thus, the 
maximum likelihood estimate can be found using the following iterative algorithm [24]: 
1. Set 00 =D  and apply nonlinear least squares, to find 0βˆ  and compute the residuals 
)ˆ(logˆ 0βiii fye −= . 
2. Find estimates for 2σ  and D by iterating until convergence, 
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where s is the iteration index and sλ  is a positive step length (typically 1=sλ ). Matrix H is 
defined by (7.2.2.11), and the derivatives of l  with respect to the variance parameters are given 
by  
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68 
 
for ii ee ˆ= . 
3. Find the weighted NLS solution, 1βˆ , to 
      ∑
=
−
−+−=
m
i
iiiiii fyDZZIfy
1
1
1 ))((log)'())'((logmin
ˆ βββ β                  (7.2.2.18) 
where DD ˆ=  from step 2. Compute )ˆ(logˆ 1βiii fye −=  
4. Return to step 2 if the convergence criterion is not met. 
 
To predict the response, since for two random effects model, 
)])exp(2)2exp((
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)exp(exp[)( 2012
2
112
2
00210 σσασασααα +−−−++−−= tttyE iiiiiit   (7.2.2.19) 
and for one random effect model  
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we define  
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for two random effect model and  
)]ˆˆ(
2
1
)ˆexp(ˆˆexp[ˆ 2200210 σσααα ++−−= ty iiiit  for one random effect model.         (7.2.2.22) 
 
7.3 PRESS residuals and weighted adjusted PRESS (WAPRESS) 
The residual is defined to be the difference between the predicted value evaluated through 
the estimated model, and the observed value. Since the estimated model is derived from all 
observations including the one we want to predict, the residual tends to be smaller than it is 
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supposed to be. This is what we defined as the “shrinkage”. One way to find more reasonable 
residual is to take away the observation we want to predict in the process of estimating the model. 
In the other words, using n-1 (n is the sample size) observations to estimate the model leaving 
one observation out. The PRESS residual is the difference between the estimated value on this 
observation and the true observed value. PRESS statistic is defined to be the sum of square 
PRESS residuals, which includes all n observations. It can be expressed as  
                               ∑
=
−
−
n
i
ii YY
1
2
)( )
ˆ(                              (7.3.1) 
where 
iY  is the ith observation and )(
ˆ
iY −  is the estimated iY  without using the ith observation, 
i = 1, 2, …, n. 
Since the dataset in this study is longitudinal data which has repeated SB-IV test 
measurements obtained from each patient over time. It is more reasonable to adjust the PRESS 
residuals by taking away the observations of one specified patients we want to predict in the 
process of estimating the model. In the other words, using inN −  (N is the sample size and in  
is the number of observations for the ith patients) observations to estimate the model leaving in  
observations out. And the adjusted PRESS residuals are the difference between the estimated 
values on those 
in  observations and the true observed values. The adjusted PRESS statistic is 
defined to be the sum of square adjusted PRESS residuals, which includes all N observations. It 
can be express as 
                           ∑
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N
j
jji YY
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2
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ˆ(                                    (7.3.2) 
where jY  is the ith observation and ])[(
ˆ
jiY −  is the estimated jY  without using the in  
observations from the ith patient to which the jth observation belongs,  j= 1, 2, …, N. 
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Since number of observations for each patient is different, it is reasonable to weight the 
adjusted PRESS residuals by the number of observations for each patient. We define weighted 
adjusted PRESS (WAPRESS) as  
              ∑ ∑
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m
i
n
j
ijji
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YY
n
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1 1
2
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1
 (7.3.3) 
where ijY  is the jth observation of ith patient, inj ,...1=  and mi ,...1= , and jiY )(
ˆ
−
 is the 
estimated ijY  without using the in  observations from the ith patient. 
 
7.4 VUS 
According to hierarchical linear model or Gompertz model, we can predict the SB-IV test 
scores for different time points of patients. In some case, the scores are grouped to different 
levels, such as “low”, “median”, “high”. Then VUS proposed in the first part of dissertation can 
be applied as criterion to evaluate the goodness of the models. Different from PRESS, the VUS 
of one model is higher if the predictions of observations are more correctly classified instead of 
closer to the true scores. The details of new proposed VUS criterion can be found in the first five 
chapters of this dissertation. 
 
7.5 Statistical analysis 
SAS PROC MIXED and PROC NLMIXED provides a very flexible ways to model many 
types of repeated measures data. In this dissertation, PROC MIXED is used to build hierarchical 
linear models on two sets of predictors and PROC NLMIXED is applied to construct Gompertz 
based hierarchical nonlinear models on two sets of predictors. Since the analysis procedure of the 
five response variables is similar, in this part, we only show the analysis of SB-IV composite IQ 
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score. The details of the other four responses are attached in the appendix. In this study, 
backward elimination is applied to do model selection. 
 
7.5.1 Hierarchical linear model 
7.5.1.1 Hierarchical linear model for treatments and other variables 
The variables interested are Years between date of treatment and date of exam (Time), 
Gender, Age group, SES classes, Treatments (radiation and chemotherapy).  The patients are 
divided into two age groups according to the age of diagnosis at cutting point seven-year-old. 
Based on Chemotherapy (0=No, 1=Yes), Radiation (0=No, 1=Yes), Age group (0: age at 
diagnosis is less than 7 years old, 1: otherwise), Gender (1=Female, 0=Male), and SES class (1, 
2, 3, 4, 5), 80 categories are defined. 
Two models are considered in this section: Model1: Linear model without interaction 
among risk factors; Model 2: Quadratic model without interaction. In this set of variables, for 
either linear model or quadratic model, no interaction is significant among risk factors. 
Table 7.1 shows the solution for fixed effects of Model 1. Table 7.2 presents the random 
effects which is the variances of the intercept and linear slope. 
 
Table 7.1 Fixed effects for the hierarchical linear model without interactions  
for treatments and other variables 
                         Standard 
Effect       Estimate     Error         DF     Pr > |t| 
Intercept      113.30      3.9511        92       <.0001 
SES          -7.0601     1.1457       295       <.0001 
age_g         8.3044     2.7355       295       0.0026 
rad*time      -2.1324      0.4357       295       <.0001 
SES*time      0.3167      0.1145       295       0.0061 
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Table 7.2 Random effects for the hierarchical linear model without interactions  
for treatments and other variables 
                            Standard      Z 
    Cov Parm     Estimate    Error       Value        Pr Z 
     UN(1,1)      154.08     28.2940      5.45      <.0001 
     UN(2,1)     -0.8865      3.5055      -0.25      0.8004 
     UN(2,2)      1.5312      0.7334      2.09      0.0184 
 
 
The final expression for Model 1 is  
    )0601.7_3044.830.113( 0iiiit SESgroupAgeCompiq µ+−+=
       
ititiiit TimeSESRad εµ +++−+ )3167.01324.2( 1                 (7.5.1) 
 
Table 7.3 shows the solution for fixed effects of Model 2. Table 7.4 presents the random 
effects which is the variances of the intercept and linear slope. 
 
Table 7.3 Fixed effects for the hierarchical quadratic model without interactions  
for treatments and other variables 
    Standard 
Effect       Estimate        Error      DF     Pr > |t| 
Intercept       114.74      3.7944      93      <.0001 
SES          -6.4198      1.1372     293       <.0001 
time2         0.07803     0.03204     293       0.0155 
rad*time       -2.0928     0.3940      293       <.0001 
time*age_g     3.1841      0.9433     293       0.0008 
time2*age_g   -0.3518       0.1452     293       0.0160 
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Table 7.4 Random effects for the hierarchical quadratic model without interactions  
for treatments and other variables 
                            Standard      Z 
    Cov Parm     Estimate     Error       Value       Pr Z 
     UN(1,1)      153.30     28.1212      5.45      <.0001 
UN(2,1)     -0.8923      3.5294      -0.25      0.8004 
UN(2,2)      1.5581      0.7340      2.12       0.0169 
 
 
The final expression for Model 2 is  
itiiti
iiit
TimeRadiationgroupAge
SESCompiq
)0928.2_1841.3(
)4198.674.114(
1
0
µ
µ
+−+
+−=
          
ititi TimegroupAge ε+−+
2
)_3518.007803.0(                                (7.5.2) 
 
7.5.1.2 Hierarchical linear model for neurological predictor scale and other variables 
The variables interested are Years between date of treatment and date of exam (Time), 
Gender, Age group, SES classes, Neurological Predictor Scale (NPS). The patients are divided 
into two age groups according to the age of diagnosis at cutting point seven-year-old. 
Four models are considered in this section: Model3: Linear model without interaction 
among risk factors; Model 4: Linear model with interaction; Model5: Quadratic model without 
interaction among risk factors; Model 6: Quadratic model with interaction; 
Table 7.5 shows the solution for fixed effects of Model 3. Table 7.6 presents the random 
effects which is the variances of the intercept and linear slope. 
 
 
74 
 
 
Table 7.5 Fixed effects for the hierarchical linear model without interactions  
for NPS and other variables 
                         Standard 
Effect       Estimate     Error         DF     Pr > |t| 
Intercept      117.43     4.5235        92     <.0001 
SES         -6.2047     1.1087       294     <.0001 
age_g        8.0850     2.6447       294     0.0024 
NPS        -1.3286      0.5134       294     0.0101 
time         2.0333      0.7307       94      0.0065 
NPS*time    -0.3520      0.1121       294     0.0019 
 
Table 7.6 Random effects for the hierarchical linear model without interactions  
for NPS and other variables 
                            Standard      Z 
 Cov Parm        Estimate     Error       Value      Pr Z 
 UN(1,1)          147.84     27.3825      5.40      <.0001 
 UN(2,1)         -2.9432      3.7870      -0.78      0.4371 
 UN(2,2)          2.1696      0.8721      2.49      0.0064 
 
The find expression for Model 3 is  
ititiitiit
iiit
TimeNPSNPS
groupAgeSESCompiq
εµµ ++−++−
+−=
)3520.00333.2()3286.1
_0850.82047.643.117(
10   (7.5.3) 
Table 7.7 shows the solution for fixed effects of Model 4. Table 7.8 presents the random 
effects which is the variances of the intercept and linear slope. 
 
The final expression of Model 4 is  
ititiit
iiitiiti
iiit
TimeNPS
SexNPSSESNPSSex
SESgroupAgeCompiq
εµ
µ
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−+=
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Table 7.7 Fixed effects for the hierarchical linear model with interactions  
for NPS and other variables 
                         Standard 
Effect       Estimate        Error      DF     Pr > |t| 
Intercept      108.57       5.1260      91      <.0001 
SES        -10.4269       2.2729     293      <.0001 
age_g        9.0307       2.6034     293      0.0006 
Sex         14.8456       5.1080     293      0.0039 
time         2.0887        0.7273     94      0.0050 
SES*NPS    0.7480        0.3562     293      0.0366 
Sex*NPS    -2.5682        0.7919     293      0.0013 
time*NPS   -0.3600        0.1115     293      0.0014 
 
Table 7.8 Random effects for the hierarchical linear model with interactions  
for NPS and other variables 
                            Standard         Z 
 Cov Parm        Estimate      Error       Value       Pr Z 
 UN(1,1)           140.43     26.2541      5.35      <.0001 
 UN(2,1)           -3.1681     3.6042      -0.88      0.3794 
 UN(2,2)           2.1660      0.8608      2.52      0.0059 
 
Table 7.9 shows the solution for fixed effects of Model 5. Table 7.10 presents the random 
effects which is the variances of the intercept and linear slope. 
 
Table 7.9 Fixed effects for the hierarchical quadratic model without interactions  
for NPS and other variables 
                         Standard 
Effect       Estimate        Error      DF    Pr > |t| 
Intercept      117.40      4.4872      92     <.0001 
SES         -6.3331      1.1068     292     <.0001 
NPS         -1.1470      0.5440     292     0.0359 
age_g         7.7608      2.6463    292     0.0036 
time2         0.2486      0.1054     292     0.0190 
Sex*time      1.2789      0.4249     292     0.0028 
NPS*time     -0.3735      0.1117     292     0.0009 
       time2*Sex     -0.1485     0.06366     292     0.0204 
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Table 7.10 Random effects for the hierarchical quadratic model without interactions  
for NPSand other variables 
                            Standard       Z 
    Cov Parm     Estimate      Error      Value      Pr Z 
    UN(1,1)       145.59     27.1064      5.37      <.0001 
    UN(2,1)      -2.4145      3.8207      -0.63      0.5274 
    UN(2,2)       2.1739      0.8807      2.47      0.0068 
 
 
The final expression of Model 5 is  
ititiitiiit
iiitiit
TimeSexTimeSexNPS
groupAgeNPSSESCompiq
εµ
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                                                                                 (7.5.5)
 
 
Table 7.11 shows the solution for fixed effects of Model 6. Table 7.12 presents the 
random effects which is the variances of the intercept and linear slope. 
 
Table 7.11 Fixed effects for the hierarchical quadratic model with interactions  
for NPS and other variables 
                         Standard 
Effect       Estimate        Error      DF     Pr > |t| 
Intercept      112.24       5.1395      91      <.0001 
SES        -11.1305       2.2850     291      <.0001 
age_g        8.9409       2.5964     291      0.0007 
Sex         13.5522       5.0925     291      0.0082 
time2        0.2507       0.1044      291      0.0169 
SES*NPS     0.8660       0.3595     291      0.0166 
Sex*NPS     -2.7321       0.7948     291      0.0007 
NPS*time    -0.4151       0.1109     291       0.0002 
Sex*time     1.4826       0.4348      291      0.0007 
Sex*time2    -0.1483      0.06328      291      0.0198 
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Table 7.12 Random effects for the hierarchical quadratic model with interactions  
for NPS and other variables 
                            Standard       Z 
    Cov Parm     Estimate      Error      Value      Pr Z 
    UN(1,1)       136.75     25.7335      5.31      <.0001 
    UN(2,1)      -2.5404      3.6020      -0.71      0.4806 
    UN(2,2)       2.1330      0.8533      2.50      0.0062 
 
The final expression of Model 6 is  
ititi
itiiti
iitiiti
iiiit
TimeSex
TimeNPSSex
NPSSexNPSSES
SexgroupAgeSESCompiq
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7.5.2 Gompertz based hierarchical nonlinear model 
7.5.2.1 Gompertz based hierarchical nonlinear model for treatments and other variables 
The variables interested are Years between date of treatment and date of exam (Time), 
Gender, Age group, SES classes, Radiation and Chemotherapy. The patients are divided into two 
age groups according to the age of diagnosis at cutting point seven-year-old. 
One model is considered in this section: Model7: Gompertz based hierarchical nonlinear 
model without interaction among risk factors. For this model, no interaction is significant among 
risk factors. 
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Table 7.13 shows the solution for fixed effects and variance of random effects of Model 7.  
 
Table 7.13 Fixed effects and variance of random effect for the Gompertz based nonlinear 
hierarchical model without interactions for treatments and other variables 
                             Standard 
      Parameter    Estimate       Error      DF     Pr > |t|             
beta00         4.7174     0.04348      94     <.0001             
beta01         0.1320     0.03270      94     0.0001      
      beta02       -0.06447     0.01244      94     <.0001      
      beta03        -0.1192     0.02879      94     <.0001    
      beta11         0.1071     0.03021      94     0.0006           
      beta12        -0.1840     0.02512      94     <.0001          
      beta21         0.3861      0.1673      94     0.0232          
      sigmae       0.006364    0.000456      94     <.0001      
      sigmau1       0.01862    0.002943      94     <.0001     
 
The final expression for model 7 is  
it
TimeSex
iti
iiti
iit
itieRadiationgroupAge
RadiationSES
groupAgeCompiq
ε
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+−−
+−−
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− )3861.0(
0
)1840.0_1071.0(
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              (7.5.7)
 
 
7.5.2.2 Gompertz based hierarchical nonlinear model for neurological predictor scale and 
other variables 
The variables interested are Years between date of treatment and date of exam (Time), 
Gender, Age group, SES classes, Neurological Predictor Scale (NPS). The patients are divided 
into two age groups according to the age of diagnosis at cutting point seven-year-old. 
2 models are considered in this section: Model8: Gompertz hierarchical nonlinear model 
without interaction among risk factors; Model 9: Gompertz hierarchical nonlinear model with 
interaction. 
79 
 
 
Table 7.14 shows the solution for fixed effects and variance of random effects of Model 8. 
 
Table 7.14 Fixed effects and variance of random effect for the Gompertz based nonlinear 
hierarchical model without interactions for NPS and other variables 
                            Standard 
     Parameter    Estimate       Error      DF       Pr > |t|       
beta00         4.9967     0.05623      94       <.0001      
beta01        0.07350     0.02751      94       0.0089       
     beta02       -0.08743     0.01258      94       <.0001     
     beta03       -0.04390    0.006028      94       <.0001       
     beta10         0.2742     0.04944     94       <.0001         
     beta11       -0.02577    0.008297      94       0.0025      
     beta12       -0.04275    0.006383      94       <.0001        
     beta21        -0.2538     0.03815      94       <.0001       
     beta22         0.2455     0.07762      94       0.0021        
     beta23         0.1381     0.02457      94       <.0001        
    sigmae       0.006099    0.000437       94       <.0001     
    sigmau1       0.01577    0.002525       94       <.0001     
 
The final expression for model 8 is  
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                                                                         (7.5.8) 
Table 7.15 shows the solution for fixed effects and variance of random effects of Model 9.  
 
The final expression for model 9 is  
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Table 7.15 Fixed effects and variance of random effect for the Gompertz based nonlinear 
hierarchical model with interactions for NPS and other variables 
                            Standard 
     Parameter    Estimate       Error      DF       Pr > |t|             
beta00         5.0313     0.05424      94     <.0001        
      beta01       -0.09848     0.01306      94     <.0001      
      beta02       -0.04370    0.006028      94     <.0001      
      beta03        0.02280    0.008292      94     0.0072     
      beta10         0.2747     0.04941      94     <.0001       
      beta11       -0.02589    0.008285      94     0.0024      
      beta12       -0.04275    0.006382      94     <.0001      
      beta21        -0.2538     0.03810      94     <.0001      
      beta22         0.2479     0.07798      94     0.0020      
      beta23         0.1376     0.02443      94     <.0001      
      sigmae       0.006100    0.000437      94     <.0001     
      sigmau1       0.01569    0.002515      94     <.0001      
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CHAPTER 8 
Model comparison and interpretation 
 
In this chapter, we use WAPRESS and VUS as criterions to compare the nine models 
about composite IQ presented in chapter 7. Also the relationship between the risk factors and 
composite IQ for the nine models are discussed respectively. The comparison and interpretation 
for the other four responses can be found in the appendix. 
 
8.1 Model comparison using WAPRESS 
Table 8.1 presents the weighted adjusted PRESS for nine models. No interaction is 
significant for radiation & chemotherapy models.  
From Table 8.1 we found that for all cases, Gompertz based hierarchical nonlinear 
models yield better WAPRESS results than hierarchical linear/quadratic models. And 
furthermore, Gompertz improved more for NPS models. It shows the merit of Gompertz 
structure.  
For the two sets of predictors, Neurological Predictor Scale models always perform better 
than radiation & chemotherapy models. It is because Neurological Predictor Scale includes more 
information than simple radiation and chemotherapy model. Then it can be an evidence that NPS 
is good criterion for measure the patients’ treatment condition and medical complications. 
And we can see in hierarchical linear models, adding quadratic terms does not seem to 
have significantly better results. But for NPS models, models with interaction yields better 
WAPRESS than the models without interaction. 
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Table 8.1 WAPRESS for composite IQ models 
 
Hierarchical linear/quadratic Model      Without interaction 
     Time    Time^2 
Gompertz Model
    Radiation & Chemo 19591.82 19335 19055.68 
Neurological Predictor Scale 18857.45 19091.45    17149.66 
 
Hierarchical linear/quadratic Model       With interaction 
    Time    Time^2 
Gompertz Model
    Radiation & Chemo        NA       NA       NA 
Neurological Predictor Scale     18313.01     18506.5     17136.92 
 
 
8.2 Model comparison using VUS 
Weighted Adjusted PRESS measures how close the predicted response to the observed 
one. Sometimes we are more interested in classifying the response variable into several ordered 
levels, such as our grade system in schools of this country. VUS can be used to measure and 
compare the models constructed in previous section. Since the IQ score in this study is for the 
pediatric patients whose IQ will be lower than the common population, the regular classification 
should not be used to group the IQ score. In this study, we assume the IQ is normal and group the 
IQ into three and four levels such that for each level, the population is approximately even. Then 
the cutoff point for 3-level case is: Low: <86, Median: 86-100, High: >100. The cutoff point for 
4-level case is Low: <82, Median low: 82-93, Median high: 94-104, High: >104.  
We use the predictive value in the nine models stated in chapter 2 and the output of 3-
level VUS and linear/quadratic transformed VUS are presented in table 8.2 and 4-level VUS and 
linear/cubic transformed VUS are presented in table 8.3. These two tables show the performance 
of the models corresponding to their power of classification. It is not hard to notice the advantage 
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of Gompertz model structure. It is also interesting to note that the prediction is better for 3-level 
responses than that of 4-level responses. This might indicate that it is harder to predict more 
precise IQ scores. 
  
Table 8.2 3-level VUS and transformed VUS for composite IQ models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo 0.3589856 
(0.749521) * 
(0.78737) ** 
0.3526003 
(0.741662) 
(0.779826) 
0.3633188 
(0.754854) 
(0.792452) 
Neurological Predictor Scale 0.3787719 
(0.773873) 
(0.810333) 
   0.377479 
(0.772282) 
(0.808851) 
    0.402626 
(0.803232) 
(0.837233) 
           
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo  NA NA NA 
Neurological Predictor Scale    0.379855 
(0.775206) 
(0.811573) 
   0.3765946 
(0.771193) 
(0.807836) 
    0.4003582 
(0.800441) 
(0.834711) 
                                   (* linear transformed VUS      **quadratic transformed VUS) 
 
Table 8.3 4-level VUS and transformed VUS for composite IQ models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo  0.0881244 
(0.654734) * 
    (0.734454) ** 
 0.0850012 
(0.646739) 
(0.7257) 
 0.0938991 
 (0.669517) 
(0.750109) 
Neurological Predictor Scale  0.0955790 
(0.673818) 
(0.754542) 
0.094217 
(0.670331) 
(0.750952) 
   0.1060152 
   (0.700535) 
(0.78098) 
 
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo        NA NA     NA 
Neurological Predictor Scale     0.0949701 
    (0.672259) 
    (0.752941) 
0.0944536 
    (0.670937) 
    (0.751578) 
0.1049884 
   (0.697906) 
   (0.778458) 
                                      (* linear transformed VUS      **cubic transformed VUS) 
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8.3 Model interpretation  
In this section, the effect of each risk factor to the composite IQ score will be discussed 
from the results of the nine models stated in chapter 2. Chemotherapy is not significant in all nine 
models, and then here five risk factors (Age group, SES, Sex, Radiation, NPS) are analyzed 
separately. 
 
8.3.1 Effect of age group 
Table 8.4 shows the effect of older age at diagnosis (more than 7 years old at diagnosis). 
We can find individuals whose age is 7 years old or older at diagnosis will have higher composite 
IQ than those whose age is younger than 7 years old in eight models. Treatment hierarchical 
quadratic model shows that the benefit of older age at diagnosis only lasts 9 years after diagnosis. 
Gompertz based hierarchical nonlinear models also provide more information: the benefit of 
older age at diagnosis is larger in female than male (see figure 8.1); the lower socioeconomic 
status class, the more benefit of older age at diagnosis (see figure 8.2).  
In figure 8.1, composite IQ of patients whose age is less than 7 years old and more than 7 
years old at diagnosis are compared in both male and female patients who have SES=3 with 
radiation. In figure 8.2, composite IQ of patients whose age is less than 7 years old and more than 
7 years old at diagnosis are compared in both low SES (SES=5) and high SES (SES=1) male 
patient with NPS=8. 
 
8.3.2 Effect of socioeconomic status class 
Table 8.5 shows the effect of socioeconomic status class to composite IQ score. Most of 
the models show that low SES is associated with lower composite IQ. And from the treatment 
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Table 8.4 Effect of age group to composite IQ score 
           Model 
   
groupAge
IQ
_∂
∂
 or 
groupAge
IQ
_
log
∂
∂
 
Model 1 (treatment linear w/o inter) 3043.8  
Model 2 (treatment quadratic w/o inter)         23518.01841.3 tt −  
Model 3 (NPS linear w/o inter)             085.8  
Model 4 (NPS linear w/ inter)             0307.9  
Model 5 (NPS quadratic w/o inter)             7608.7  
Model 6 (NPS quadratic w/ inter) 9409.8  
Model 7 (treatment Gompertz w/o inter)    )**3861.0exp(1071.0132.0 tSex−−  
Model 8 (NPS Gompertz w/o inter) 0735.0  
Model 9 (NPS Gompertz w/ inter) SES0228.0  
 
 
Figure 8.1 Composite IQ comparison between age groups in different sex in model 7 
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Figure 8.2 Composite IQ comparison between age groups in low and high SES in model 9 
 
hierarchical linear model we can find as time passing, the harm will go smaller. And NPS 
hierarchical linear/quadratic models show the higher NPS score, the lower harm low SES will 
give (see figure 8.3). The interpretation of SES effect in NPS Gompertz based hierarchical 
nonlinear models is not clear due to the complex structure of the models. 
In figure 8.3, composite IQ of patients who have low SES (SES=5) and high SES 
(SES=1) are compared in both low NPS (NPS=0) and high NPS (NPS=10) male patient whose 
age is more than 7 years old at diagnosis. 
 
8.3.3 Effect of sex 
Table 8.6 shows the effect of sex to composite IQ score. Sex is significant in six out of 
nine models. The hierarchical linear/quadratic models show that when NPS is low and time after 
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Table 8.5 Effect of socioeconomic status class to composite IQ score 
           Model 
         
SES
IQ
∂
∂
 or 
SES
IQ
∂
∂ log
 
Model 1 (treatment linear w/o inter) t3167.00601.7 +−  
Model 2 (treatment quadratic w/o inter)             4198.6−  
Model 3 (NPS linear w/o inter)             2047.6−  
Model 4 (NPS linear w/ inter)        NPS748.04269.10 +−  
Model 5 (NPS quadratic w/o inter)             3331.6−  
Model 6 (NPS quadratic w/ inter) NPS866.01305.11 +−  
Model 7 (treatment Gompertz w/o inter)            0.06447−  
Model 8 (NPS Gompertz w/o inter) 
}t0.1381NPS)-0.2455Sex-(0.2538SESexp{*
)*01.0*0065.0007.0026.0(088.0 tNPStSESt ++++−  
Model 9 (NPS Gompertz w/ inter) 
}t0.1376NPS)-0.2479Sex-(0.2538SESexp{*
)*01.0*0066.0007.0026.0(_02.01.0 tNPStSEStgroupAge +++++−  
 
 
Figure 8.3 Composite IQ comparison between low and high SES in low and high NPS in model 4 
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diagnosis is long, male have higher composite IQ than female. Otherwise, when NPS is high and 
time after diagnosis is short, female have higher composite IQ. And treatment Gompertz based 
hierarchical nonlinear model shows that for those whose age is 7 years older at diagnosis and 
without radiation, female have higher composite IQ than male. For those whose age is 7 years 
younger at diagnosis and without radiation, female and male make no difference in composite IQ. 
For those who have radiation, female have lower composite IQ than male (see figure 8.4). NPS 
Gompertz based hierarchical nonlinear models show that when SES is high and NPS is low, male 
have higher composite IQ than female. Otherwise, when SES is low and NPS is high, female 
have higher composite IQ. If both SES and NPS are high or low, it depends. 
( 0.043NPS-0.026SES-0.275 >0, then female have higher composite IQ. Otherwise, male have 
higher composite IQ). (see figure 8.5) 
In figure 8.4, composite IQ of male and female patients are compared in four 
combinations of patient whose age is less and more than7 years old at diagnosis with and without 
radiation in SES=3 . 
In figure 8.5, composite IQ of male and female patients are compared in four 
combinations of low and high SES (SES=5 and 1) and low and high NPS (NPS=0 and 10) whose 
age is more than7 years old at diagnosis. 
 
8.3.4 Effect of radiation 
Table 8.7 shows the effect of radiation to composite IQ score. The hierarchical 
linear/quadratic models show that radiation is harmful for the patients’ composite IQ and as time 
passing, the harm will increase. And treatment Gompertz based hierarchical nonlinear model 
shows that for female, 0.55 years after diagnosis, and for male, 1.1 years after diagnosis patients 
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Table 8.6 Effect of sex to composite IQ score 
           Model 
        
Sex
IQ
∂
∂
 or 
Sex
IQ
∂
∂ log
 
Model 1 (treatment linear w/o inter) N/A
 
Model 2 (treatment quadratic w/o inter) 
             
N/A
 
Model 3 (NPS linear w/o inter) 
             
N/A
 
Model 4 (NPS linear w/ inter)        NPS5682.28456.14 −  
Model 5 (NPS quadratic w/o inter)          21485.02789.1 t−  
Model 6 (NPS quadratic w/ inter) 21483.04826.17321.25522.13 ttNPS −+−  
Model 7 (treatment Gompertz w/o inter)    
)**3861.0exp(
*)184.0_1071.0(33861.0
tSex
RadgroupAget
−
−  
Model 8 (NPS Gompertz w/o inter) 
t}0.1381NPS)-0.2455Sex-8SESexp{(0.253
*0.043NPS)-0.026SES-0.275(2455.0 t  
Model 9 (NPS Gompertz w/ inter) 
t}0.1376NPS)-0.2479Sex-8SESexp{(0.253
*0.043NPS)-0.026SES-0.275(2479.0 t  
 
 
with radiation starts to have lower composite IQ than patients without radiation and as time 
passing, the harm will increase. Also the harm of radiation is larger in female patients than male 
patients (see figure 8.6). 
In figure 8.6, composite IQ of patients with and without radiation are compared in both 
male and female patient whose age is more than 7 years old at diagnosis with SES=3 . 
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Figure 8.4 composite IQ comparison between male and female in different age group and 
radiation in model 7 
 
 
Figure 8.5 composite IQ comparison between male and female in different SES and NPS group 
in model 9 
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Table 8.7 Effect of radiation to composite IQ score 
           Model 
     
Radiation
IQ
∂
∂
 or 
Radiation
IQ
∂
∂ log
 
Model 1 (treatment linear w/o inter) t1324.2−  
Model 2 (treatment quadratic w/o inter)            t0928.2−  
Model 7 (treatment Gompertz w/o inter)   )**3861.0exp(184.01192.0 tSex−+−  
 
 
Figure 8.6 composite IQ comparison between radiation group in different sex in model 7 
 
8.3.5 Effect of neurological predictor scale 
Table 8.8 shows the effect of neurological predictor scale to composite IQ score. The 
hierarchical linear/quadratic models show that higher NPS will lead to lower composite IQ 
shortly after diagnosis and SES is higher (see figure 8.7), the harm of high NPS is larger. Also 
female will have more harm for high NPS than male (see figure 8.8). Furthermore, as time 
passing, the harm will increase. For Gompertz based hierarchical nonlinear model, the effect is 
not clear due to complex model structure. 
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In figure 8.7, composite IQ of patients with low NPS (NPS=0) and high NPS (NPS=10) 
are compared in both low SES (SES=5) and high SES (SES=1) female patient whose age is more 
than 7 years old at diagnosis. 
In figure 8.8, composite IQ of patients with low NPS (NPS=0) and high NPS (NPS=10) 
are compared in both male and female patient whose age is more than 7 years old at diagnosis 
with SES=3 . 
 
Table 8.8 Effect of neurological predictor scale to composite IQ score 
           Model 
        
NPS
IQ
∂
∂
 or 
NPS
IQ
∂
∂ log
 
Model 3 (NPS linear w/o inter)           t352.03286.1 −−  
Model 4 (NPS linear w/ inter)       tSexSES 36.05682.2748.0 −−  
Model 5 (NPS quadratic w/o inter)          t3735.0147.1 −−  
Model 6 (NPS quadratic w/ inter) tSexSES 4151.07321.2866.0 −−  
Model 8 (NPS Gompertz w/o inter) 
t}0.1381NPS)-0.2455Sex-8SESexp{(0.253
*t)*0.006NPS-t*0.0036SES-0.0038t(0.0430.044- ++  
Model 9 (NPS Gompertz w/ inter) 
t}0.1376NPS)-0.2479Sex-8SESexp{(0.253
*t)*0.006NPS-t*0.0036SES-0.0038t(0.0430.044- ++  
 
8.4 Difference between hierarchical linear/quadratic model and Gompertz based 
hierarchical nonlinear model in interpretation 
Table 8.9 present some different interpretation between hierarchical linear/quadratic 
models and Gompertz based hierarchical nonlinear models. We can find that Gompertz models 
involve more information (interaction) than hierarchical linear/quadratic models. This  
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Figure 8.7 Composite IQ comparison between low and high NPS in low and high SES in model 6 
  
 
Figure 8.8 Composite IQ between low and high NPS in different sex in model 6 
 
is the advantage of nonlinear models. But there is still some drawback: The information in the 
nonlinear model is not as easy to interpret as in hierarchical linear/quadratic models. 
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Table 8.9 Some different interpretation between hierarchical linear/quadratic model  
and Gompertz based nonlinear model 
Variable Hierarchical Linear/quadratic Model Gompertz based nonlinear model 
Age group Simple positive effect Positive effect involved Sex and 
SES into interpretation 
SES Positive effect involve NPS into 
interpretation 
Simple positive effect or hard to 
interpret 
Sex Involve NPS into interpretation Involve age group, radiation, SES 
and NPS into interpretation 
Radiation Simple negative effect Negative effect involve Sex into 
interpretation 
NPS Negative effect Involve SES and Sex 
into interpretation 
Hard to interpret 
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CHAPTER 9 
Conclusion and future research 
 
The new proposed VUS is an improved criterion for measuring the multi-class diagnostic 
accuracy by considering both sensitivity and specificity. And the estimation and inference is 
relatively easy to obtain. It is can be used as a tool in distinguishing the quality of given multi-
classifier in diagnostic tests.  
In the longitudinal study, the analysis using hierarchical linear/quadratic model and 
Gompertz based hierarchical nonlinear model shows the trend of pediatric brain-tumor patients’ 
SB-IV test scores (specially, Composite IQ score) over time after diagnosis and the effect of each 
risk factors. The study validates the the finding of [25, 26] that the use of radiation therapy may 
cause the risk of suboptimal cognitive outcomes even though it can increase the survival rate. 
Also the model comparison and interpretation show the merit and drawback of Gompertz 
structure: Gompertz based hierarchical nonlinear model fits the data better but causes difficulty 
of model interpretation in some cases.  
To construct models that fit the data better, some model transformation method can be 
applied and different model selection method may be employed. Also future study can be focused 
on how to conquer the difficulty of model interpretation for Gompertz based hierarchical 
nonlinear model.  
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APPENDIX A 
List of abbreviations 
ROC: Receiver operating characteristic 
AUC: The area under the ROC curve 
STB-IV: Stanford-Binet Intelligence Scale-Fourth Edition 
IQ: intelligence quotient 
VUS: Volume under the surface 
PRESS: Prediction Error Sum of Squares 
HLM: Hierarchical Linear Model 
WAPRESS: Weighted Adjusted PRESS 
SES: Socioeconomic Status 
NPS: Neurological Predictor Scale 
EL: Empirical likelihood 
ANOVA: Analysis of Variance 
ANCOVA: analysis of covariance 
ANCOVARC: analysis of covariance with reliability correction 
ML: Maximum Likelihood 
REML: Restricted/residual Maximum Likelihood 
Compiq: Composite IQ 
VRSAS: Verbal Reasoning SAS score 
AVRSAS: Abstract/Visual Reasoning SAS score 
QVRSAS: Quantitative Reasoning SAS score 
STMSAS: Short-Term Memory SAS score 
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APPENDIX B 
Analysis of four STB SAS scores 
Verbal reasoning SAS score (VRSAS): 
Model 1 (Hierarchical R&C Time): 
ititiitiiit TimeRadSESVRSAS εµµ ++−++−= )2286.1()768.481.114( 10      
Model 2 (Gompertz R&C): 
it
TimeRadSES
ititi
iitiit
ititie
ChemoRadSES
ChemoSESVRSAS
ε
µ
+
−−−−
+−−=
+−− )0733.01113.04889.0(
0
*)09453.005833.009481.01696.0(
)08304.01479.00067.4()log(
 
Model 3: (Hierarchical NPS Time) 
ititiit
iiit
TimeNPS
SESVRSAS
εµ
µ
++−+
+−=
)3764.06503.1(
)7469.494.113(
1
0
         
Model 4 (Hierarchial NPS Time^2) 
itititiiit
iiit
TimeTimegroupAgeNPS
SESVRSAS
εµ
µ
++++−+
+−=
2
1
0
09689.0)_2933.13129.0(
)7209.491.114(
 
Model 5 (Gompertz NPS) 
it
TimeNPSSES
itiiiit
iiit
ititie
NPSSexSESNPS
SESgroupAgeVRSAS
ε
µ
+
−+−+−
−+=
−+− )2807.007793.05193.2(
0 *)03903.004946.0003086()03659.0
03532.0_06155.08321.4()log(
 
Model 6 (Hierarchical NPS Time with interaction) 
ititiitiiit
itiit
TimeNPSgroupAgeNPS
NPSSESVRSAS
εµµ ++−+++
−−=
)1182.0()_9425.0
2867.16533.482.118(
10
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Model 7 (Gompertz NPS with interaction) 
it
TimeNPSSES
itiiiiti
itiit
ititie
NPSSexSESNPSgroupAge
NPSSESVRSAS
ε
µ
+
−+−++
−−=
−+− )2898.008209.05932.2(
0 *)0392.005087.003048.0()_01179.0
03988.003515.08492.4()log(
 
Table B.1 WAPRESS for VRSAS 
Hierarchical Model      Without interaction 
    Time    Time^2 
Gompertz Model 
     Radiation & Chemo 20025.14       NA 18529.07 
           NPS 19675.25    19003.03     19924.20 
 
Hierarchical Model      With interaction 
    Time   Time^2 
Gompertz Model 
    Radiation & Chemo      NA    NA       NA 
           NPS     19355.16      NA     19635.13 
 
3-level cutoff points:  Low: <90; Median: 90-103; High: >103 
4-level cutoff points:  Low: <86; Median: 86-96; Median high: 97-107; High: >107 
 
Table B.2 3-level VUS and transformed VUS for VRSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo 0.3264778 
(0.7095111) * 
(0.7482239) ** 
NA 0.3405685  
(0.7268535) 
(0.765421) 
Neurological Predictor Scale 0.3198148  
(7013105) 
(0.7399628) 
   0.3297046 
(0.7134826) 
(0.7521944) 
    0.3142836 
(0.6945029) 
(0.7330395) 
           
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo  NA NA NA 
Neurological Predictor Scale    0.3333403 
(0.7179573) 
(0.7566447) 
   NA     0.3142469 
(0.6944577) 
(0.7329933) 
                       (* linear transformed VUS      **quadratic transformed VUS) 
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Table B.3 4-level VUS and transformed VUS for VRSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo  0.0801443 
(0.6343053) * 
    (0.711651) **   
NA  0.0880193 
 (0.6544653) 
(0.7341624) 
Neurological Predictor Scale  0.0807018 
(0.6357324) 
(0.7132919) 
0.0822927  
(0.6398052) 
(0.7179335) 
   0.0827538 
   (0.6409856) 
(0.7192676) 
 
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo        NA NA     NA 
Neurological Predictor Scale     0.0833406 
    (0.6424879) 
    (0.7209583) 
       NA 0.0824069 
   (0.6400975) 
   (0.7182643) 
                           (* linear transformed VUS      **cubic transformed VUS) 
 
Model Interpretation for VRSAS models: 
SES: 
All hierarchical models indicate lower SES score will lead to lower verbal reasoning SAS score. 
For all the Gompertz models, the trend is not clear because of the more complicated model 
structure. 
Radiation: 
Hierarchical model indicates radiation is harmful to verbal reasoning SAS score and when time is 
passing, the harm will increase. For Gompertz model, the trend is not clear because of the more 
complicated model structure. 
Chemotherapy: 
For hierarchical model, chemo is not significant. And for Gompertz model, Chemo is significant 
but the trend is not clear because of the more complicated model structure. 
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Age_group: 
For hierarchical models, age_group is significant in NPS model and indicate that the individual 
who is 7 years older at diagnosis will have higher verbal reasoning SAS score and the advantage 
of older age will increase when time is passing and also the advantage of older age is larger when 
the NPS is larger. For Gompertz model, the same conclusion will be made as hierarchical model. 
Sex: 
For all the hierarchical models, sex is not significant. But for Gompertz NPS models, sex is 
significant and we can conclude male will have higher verbal reasoning SAS score and for lower 
SES and lower NPS, the advantage of gender is larger. 
NPS: 
For all the hierarchical models, higher NPS will lead lower verbal reasoning SAS score and when 
time is passing, the harm will increase.  For all the Gompertz models, the trend is not clear 
because of the more complicated model structure. Hierarchical model with interaction indicates 
that for patient whose age is less than 7 years old at diagnosis, the harm of high NPS is larger. 
 
Abstract/visual reasoning SAS score (AVRSAS): 
Model 1 (Hierarchical R&C Time): 
ititiiti
iiiit
TimeSESRad
SESgroupAgeAVRSAS
εµ
µ
++++
++=
)0.70822.2262- (
)7.5410- _9.5203 112.20(
1
0
                        
Model 2 (Gompertz R&C): 
it
TimeSex
itiit
iiit
itieRadRad
SexgroupAgeAVRSAS
εµ +−+
+=
− 0.1983 
0 )0.2205-0.1998 ()0.2038-
0.05444-_0.098764.8207 ()log(
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Model 3: (Hierarchical NPS Time) 
ititiitiit
iiit
TimeNPSNPS
groupAgeSESAVRSAS
εµµ ++++
+=
)0.3376-3.2861 ()1.8857-
 _9.2328  5.1356-  114.06(
10
         
Model 4 (Gompertz NPS) 
it
Time
ti
iiiit
iteNPS
SESgroupAgeAVRSAS
ε
µ
+−
++=
−0.06281
0
0.02870
)0.05716-_0.098374.8015 ()log(
 
Model 5 (Hierarchical NPS Time with interaction) 
ititiit
iiiiit
iiit
TimeNPS
SexSESSexNPS
groupAgeSexAVRSAS
εµ
µ
+++
+
++=
)0.3249- 3.2786 (
)3.4872-1.5480-
_9.3322 19.539487.3320(
1
0        
 
Table B.4 WAPRESS for AVRSAS 
Hierarchical Model      Without interaction 
    Time    Time^2 
Gompertz Model 
    Radiation & Chemo  27252.15        NA 25222.99 
          NPS   26276.53      NA    21526.71 
 
Hierarchical Model       With interaction 
    Time    Time^2 
Gompertz Model 
    Radiation & Chemo      NA      NA         NA 
         NPS      26171.48        NA         NA 
 
3-level cutoff points:  Low: <87; Median: 87-102; High: >102 
4-level cutoff points:  Low: <83; Median: 83-94; Median high: 95-107; High: >107 
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Table B.5 3-level VUS and transformed VUS for AVRSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo 0.2925914  
(0.6678048) * 
(0.7052808) ** 
    NA 0.2992109 
(0.675951) 
(0.7138575) 
Neurological Predictor Scale 0.3188824 
(0.700163) 
(0.7388) 
   NA      0.3204386 
(0.7020782) 
(0.7407399) 
           
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo  NA NA NA 
Neurological Predictor Scale     0.3251453 
(0.7078712) 
(0.7465787) 
   NA    NA 
                       (* linear transformed VUS      **quadratic transformed VUS) 
 
 
Table B.6 4-level VUS and transformed VUS for AVRSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo  0.07982 
(0.6334751) * 
    (0.7106929) ** 
 NA  0.0795692 
 (0.632833) 
(0.7099501) 
Neurological Predictor Scale  0.0770225 
(0.6263135) 
(0.702318) 
NA    0.0863848 
   (0.650281) 
(0.729604) 
 
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo        NA NA     NA 
Neurological Predictor Scale     0.0809446 
    (0.6363541) 
    (0.7140043) 
NA NA 
                           (* linear transformed VUS      **cubic transformed VUS) 
 
 
Model Interpretation for AVRSAS models: 
SES: 
For hierarchical models, lower SES score will lead to lower Abstract/Visual Reasoning SAS 
score and when time is passing, the harm will increase. Also female individuals have more harm. 
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The Gompertz NPS model indicates lower SES will lead to lower Abstract/Visual Reasoning 
SAS score.  
Radiation: 
Hierarchical model indicates radiation is harmful to Abstract/Visual Reasoning SAS score and 
when time is passing, the harm will increase. Gompertz model indicates for male, the harm of 
radiation to Abstract/Visual Reasoning SAS score get start after 0.4 years and when time is 
passing, the harm will increase, and for female, the harm of radiation to Abstract/Visual 
Reasoning SAS score get start after 0.2 years and when time is passing, the harm will increase. 
Chemotherapy: 
Chemo is not significant for all models. 
Age_group: 
All indicates that the individual who is 7 years older at diagnosis will have higher 
Abstract/Visual Reasoning SAS score 
Sex: 
For the hierarchical models, sex is only significant in NPS model with interaction and indicates 
that female have higher Abstract/Visual Reasoning SAS score except for high NPS in low SES 
individuals. For Gompertz R&C model, the trend is not clear because of the more complicated 
model structure. 
NPS: 
For all models, higher NPS will lead lower Abstract/Visual Reasoning SAS score and when time 
is passing, the harm will increase. And hierarchical model with interaction indicates that for 
female, the harm of high NPS is larger. 
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Quantitative reasoning SAS score (QRSAS): 
Model 1 (Hierarchical R&C Time): 
ititiiit
iiit
TimeSexRad
SESQRSAS
εµ
µ
+++
+=
)0.5346--1.3953(
)5.4432- 115.48(
1
0
                         
Model 2 (Gompertz R&C): 
it
TimeRadSexSES
iti
iitiit
ititiieRadSex
ChemoSESQRSAS
ε
µ
+−
+=
++− )0.12530.12530.05564- (
0
)0.1336- 0.09956- (
)0.07408-0.08216-4.6482 ()log(
 
Model 3 (Gompertz R&C with interaction): 
it
TimeRad
iti
iiititiit
ititeRadSex
SexRadChemoSESQRSAS
ε
µ
+−
+=
− 0.105 
0
)0.2678- 0.09094- (
)0.1214-0.05708-0.06187-4.6027()log(
 
Model 4: (Hierarchical NPS Time) 
ititiitiiit TimeNPSSESQRSAS εµµ ++++= )0.2624- ()5.7879- 116.37( 10          
Model 5 (Gompertz NPS) 
it
TimeSES
ii
iitit
itieSexSES
NPSQRSAS
ε
µ
+−−
+=
+− ).1128--0.1311(
0
)0.14280.02340(
)0.01929-4.5379()log(
 
Model 6 (Hierarchical NPS Time with interaction) 
ititiitiitiiit
iiiit
TimeNPSNPSSESSexNPS
SESgroupAgeSexQRSAS
εµµ +++++
++=
)0.2265- ()1.08492.8613-
11.7858-_5.195815.7174113.18 (
10
   
Model 7 (Gompertz NPS with interaction) 
it
TimeSES
i
iitiiiit
itieSex
NPSSexSexSESQRSAS
ε
µ
+−
+=
− )0.01948(
0
)-0.2154(
)0.01272- 0.03258- 4.5075 ()log(
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Table B.7 WAPRESS for QRSAS 
Hierarchical Model     Without interaction 
    Time    Time^2 
Gompertz Model 
    Radiation & Chemo   20475.59        NA       20995.87 
          NPS 19995.72      NA       23071.07 
 
Hierarchical Model     With interaction 
    Time    Time^2 
Gompertz Model 
   Radiation & Chemo      NA      NA      20313.56 
         NPS     18953.44        NA      20412.90 
 
 
3-level cutoff points:  Low: <86; Median: 86-100; High: >100 
4-level cutoff points:  Low: <82; Median: 82-93; Median high: 94-104; High: >104 
 
Table B.8 3-level VUS and transformed VUS for QRSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo 0.326183 
(0.7091483) * 
(0.7478602) ** 
 NA 0.3327869  
(0.7172762) 
(0.7559689) 
Neurological Predictor Scale 0.3271052 
(0.7102833) 
(0.7489974) 
  NA     0.3025735 
(0.6800904) 
(0.7181779) 
           
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo  NA 
 
 
NA 0.3428007 
(0.7296008) 
(0.7681123) 
Neurological Predictor Scale    0.3448607 
(0.7321363) 
(0.7705885) 
   NA     0.3255986 
(0.7084291) 
(0.7471388) 
                       (* linear transformed VUS      **quadratic transformed VUS) 
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Table B.9 4-level VUS and transformed VUS for QRSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo  0.081203 
(0.6370154) * 
    (0.7147606) ** 
   NA  0.075581 
 (0.6226232) 
(0.697924) 
Neurological Predictor Scale  0.0755356 
(0.6225069) 
(0.6977845) 
NA    0.0702476 
   (0.6089697) 
(0.6811612) 
 
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo        NA 
 
 
NA 0.078268 
    (0.6295019) 
  (0.7060715) 
Neurological Predictor Scale     0.0787384 
    (0.630706) 
    (0.7074785) 
      NA 0.0743405 
   (0.6194474) 
   (0.6940971) 
                           (* linear transformed VUS      **cubic transformed VUS) 
 
Model Interpretation for QRSAS models: 
SES: 
All hierarchical models indicate lower SES score will lead to lower Quantitative Reasoning SAS 
score. All the Gompertz models except R&C model indicate lower SES score will lead to lower 
Quantitative Reasoning SAS score. For Gompertz R&C model, the trend is not clear because of 
the more complicated model structure. Hierarchical NPS model with interaction indicates that the 
lower of NPS, the harm of low SES will be larger. 
Radiation: 
Hierarchical model indicates radiation is harmful to quantitative reasoning SAS score and when 
time is passing, the harm will increase. For Gompertz model, the trend is not clear because of the 
more complicated model structure. 
Chemotherapy: 
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For hierarchical model, chemo is not significant. And Gompertz model indicates that chemo is 
harmful to Quantitative Reasoning SAS score. 
Age_group: 
For hierarchical models, age_group is significant in NPS model and indicate that the individual 
who is 7 years older at diagnosis will have higher Quantitative Reasoning SAS score. 
Sex: 
Hierarchical R&C model indicates male has higher Quantitative Reasoning SAS score than 
female and when time is passing, the advantage of male is larger. And Gompertz R&C model 
with interaction indicates for individual without radiation, female will have higher Quantitative 
Reasoning SAS score but for individual with radiation, male will have higher Quantitative 
Reasoning SAS score and when time is passing, the difference will be larger. Hierarchical NPS 
model with interaction indicates female individuals have higher Quantitative Reasoning SAS 
score when NPS is smaller than 6 and male individuals have higher Quantitative Reasoning SAS 
score when NPS is larger or equal to 6. 
NPS: 
For all the models, higher NPS will lead lower quantitative reasoning SAS score. And in 
hierarchical model with interaction we can find that for female, the harm of high NPS is larger 
than male and for higher SES, the harm of high NPS is larger. 
 
 
Short-term memory SAS score (STMSAS): 
Model 1 (Hierarchical R&C Time): 
ititiiit
iiiit
TimeSexRad
SESgroupAgeSTMSAS
εµ
µ
++++
++=
)0.8134-1.9732(
)5.8583-_9.1240107.87(
1
0
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Model 2 (Hierarchical R&C Time^2): 
itititi
itiiiit
iiit
TimeRadgroupAge
TimegroupAgeSexRad
SESSTMSAS
ε
µ
µ
+++
++++
+=
2
1
0
)0.1281_-0.5184(
)_4.42440.6098 -5.6126(
) 5.6126-110.43(
                        
Model 3 (Hierarchical R&C Time with interaction): 
ititiiit
iiiiit
TimeSexRad
SESgroupAgeSESSTMSAS
εµ
µ
+++
++=
)1.9712- -1.9712(
)_0.84477.2173-112.18(
1
0
                        
Model 4 (Gompertz R&C): 
it
TimeChemoSES
iiti
iitiiit
ititieRadgroupAge
RadSESgroupAgeSTMSAS
εµ
µ
+++−
++=
− )0.7412- 0.7875(
1
0
)0.0555_0.1315(
)0.09455-0.05023-_0.1231 4.6671()log(
 Model 5 (Gompertz R&C with interaction): 
it
TimeChemoSES
iitiiii
itiit
ititie
RadgroupAgeSESgroupAge
RadSESSTMSAS
ε
µµ
+
+−++
=
− )0.7364-0.7894(
10 *)0.1857-_0.1266()_0.009982
0.09188-0.06876- 4.7236()log(
 
Model 6: (Hierarchical NPS Time) 
ititiiit
iitiiit
TimeSexNPS
NPSgroupAgeSESSTMSAS
εµ
µβ
++++
+++=
) 1.1119 0.2295- (
)1.6599-_9.0006 115.47(
1
001
 
Model 7: (Hierarchical NPS Time with interaction) 
ititiiitiiit
iiitiit
TimeSexNPSSESNPS
SESgroupAgeNPSSESSTMSAS
εµµ ++++++
+=
)1.1306-0.2316()1.2909 
_2.9496 5.6364-13.9719-140.70 (
10
Model 8 (Gompertz NPS) 
it
TimeSES
iiti
iitiiit
itieNPSgroupAge
NPSSESgroupAgeSTMSAS
εµ
µ
++−
++=
−0.5167
1
0
)0.01355-_0.1202(
)0.02441-0.05659-_0.1227 4.7747()log(
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Model 9 (Gompertz NPS with interaction) 
it
TimeSES
iitiiiit
iiitiit
itie
NPSgroupAgeSESNPS
SESgroupAgeNPSSESSTMSAS
ε
µµ
+
++−++
+=
− 0.5377 
10 *)-0.01487_0.1156()0.01431 
_0.04 0.06733- 0.1536-5.0598()log(
 
Table B.10 WAPRESS for STMSAS 
Hierarchical Model     Without interaction 
    Time    Time^2 
Gompertz Model 
    Radiation & Chemo   24155.35     23977.59 24784.84 
          NPS 24304.18      NA     23672.98 
 
Hierarchical Model      With interaction 
    Time    Time^2 
Gompertz Model 
    Radiation & Chemo   23979.33     NA     24867.42 
         NPS     23845.62       NA     23359.86 
 
 
3-level cutoff points:  Low: <85; Median: 85-100; High: >100 
4-level cutoff points:  Low: <81; Median: 81-92; Median high: 93-105; High: >105 
Table B.11 3-level VUS and transformed VUS for STMSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo 0.335184 
(0.7202265) * 
(0.7588922) ** 
0.3326626 
(0.7171232) 
(0.755817) 
0.2696163  
(0.6395278) 
(0.6747334) 
Neurological Predictor Scale 0.3413209 
(0.7277796) 
(0.7663292) 
   NA      0.3457757 
(0.7332624) 
(0.7716858) 
           
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo 0.3349308 
(0.7199148) 
(0.7585839) 
NA 0.325498 
(0.7083052) 
(0.7470144) 
Neurological Predictor Scale    0.3183853 
(0.6995512) 
(0.7381794) 
   NA     0.3419241 
(0.728522) 
(0.7670566) 
                       (* linear transformed VUS      **quadratic transformed VUS) 
115 
 
 
Table B.12 4-level VUS and transformed VUS for STMSAS models 
Hierarchical linear/quadratic Model     Without interaction 
    Time   Time^2 
Gompertz Model
    Radiation & Chemo  0.0753122 
(0.6219351) * 
    (0.6970984) ** 
 0.0736045 
(0.6175634) 
(0.6918068) 
 0.059655 
 (0.5818526) 
(0.6451647) 
Neurological Predictor Scale  0.0755203 
(0.6224677) 
(0.6977376) 
NA    0.0765059 
   (0.624991) 
(0.70075) 
 
Hierarchical linear/quadratic Model       With interaction 
     Time   Time^2 
Gompertz Model
     Radiation & Chemo     0.073019 
    (0.6160644) 
    (0.6899735) 
NA    0.0646774 
   (0.5947101) 
 (0.6627219) 
Neurological Predictor Scale     0.0694119 
    (0.6068302) 
    (0.6784583) 
NA 0.0836986 
   (0.6434041) 
   (0.7219857) 
                           (* linear transformed VUS      **cubic transformed VUS) 
 
Model Interpretation for STMSAS models: 
SES: 
All hierarchical models indicate lower SES score will lead to lower Short-term Memory SAS 
score. For the Gompertz models the trend is not clear because of the more complicated model 
structure. 
Radiation: 
Hierarchical model indicates radiation is harmful to Short-term Memory and also when time is 
passing, the harm will increase. For the Gompertz models the trend is not clear because of the 
more complicated model structure. 
Chemotherapy: 
For all hierarchical models, chemo is not significant. For the Gompertz models the chemo is 
significant but the trend is not clear because of the more complicated model structure. 
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Age_group: 
Hierarchical model indicates that the individual who is 7 years older at diagnosis will have higher 
Short-term Memory SAS score. Hierarchical model with interaction indicates that for lower SES, 
the advantage of old diagnosis age is larger. Gompertz model indicates that for lower SES, the 
advantage of old diagnosis age is larger and when time is passing, the advantage of old diagnosis 
age is larger. 
Sex: 
Hierarchical R&C model indicates female has higher Short-term Memory SAS score than male 
and as time passing, the advantage will be increasing. And for all Gompertz models, sex is not 
significant. 
NPS: 
For all the hierarchical models, higher NPS will lead lower Short-term Memory SAS score and 
as time passing, the harm of high NPS is larger. Gompertz model indicates that for lower SES, 
the harm of high NPS is larger and when time is passing, the harm of high NPS is larger. 
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APPENDIX C 
Selected SAS and R code 
 
VUS calculation for some models in cervical cancer diagnosis example 
 
libname After 'H:\SAS Code for Algorithm\sas data'; 
data combine; 
set after.clean510; 
run; 
data combine; 
set combine; 
newpap=preferredpap; 
z1=p10ra32/p50ra40; 
z2=p10ra68/p50ra44; 
z3=p10ra67/p75ra42; 
z4=p25ra24/p75ra29; 
z5=p25ra67/p75ra42; 
z6=p25ra67/p75ra44; 
z7=p50ra67/p75ra42; 
z8=p75ra42/p90ra67; 
z9=p75ra43/p90ra67; 
 
r1=p10ra4/p10ra29; 
r2=p10ra5/p10ra22; 
r3=p10ra30/p10ra48; 
r4=p25ra30/p25ra45; 
r5=p50ra33/p50ra54; 
r6=p75ra31/p75ra50; 
r7=p75ra64/p75ra75; 
r8=p90ra6/p90ra29; 
r9=p90ra10/p90ra29; 
r10=p90ra32/p90ra51; 
r11=p90ra66/p90ra75; 
 
if newpap=2.8 then newpap=3.5; 
if newpap=3.2 then newpap=2; 
run; 
 
data combine; 
set combine; 
if whole1=2.5 then delete; 
else if whole1<2 then y=0; 
else if whole1>=3 then y=2; 
else y=1; 
run; 
 
proc pls data =combine; 
 model high =p25ra1 p25ra3 p25ra5 p25ra30-p25ra31 p75ra25-p75ra29 z1-z9 
newpap; 
 output out=pred pred=pred; 
run; 
 
ods listing close; 
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ods html close; 
ods trace off; 
 
ods output Association=auc; 
proc logistic data=pred; 
model high=pred; 
run; 
 
data auc; 
set auc; 
keep label2 nvalue2; 
if _n_=4; 
run; 
 
data auc; 
set auc; 
var="p25ra1 p25ra3 p25ra5 p25ra30-p25ra31 p75ra25-p75ra29 z1-z9 newpap"; 
type='    training    '; 
vus=0; 
run; 
 
data output_auc; 
set auc; 
if _n_=1 then delete; 
run; 
 
%macro sspec(datain=, applydata=, var=, scale=); 
 
********************************** 
find auc 
**********************************; 
 
data cin1out; set &datain; if whole1 not in (2.5);whole = (whole1 > 2); run;  
data apply_cin1out; set &applydata; if whole1 not in (2.5); whole = (whole1 > 
2); run;  
 
 
proc pls data = cin1out; 
 model whole= &var; 
 output out=pred pred=pred; 
run; 
 
ods listing close; 
ods html close; 
ods trace off; 
 
ods output Association=auc; 
proc logistic data=pred; 
model high=pred; 
run; 
 
data auc; 
set auc; 
keep label2 nvalue2; 
if _n_=4; 
run; 
 
data auc; 
set auc; 
var="&var"; 
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type='training'; 
run; 
 
*************************** 
find VUS 
**************************; 
 
proc pls data=combine; 
model y=&var; 
output out=out predicted=pred; 
run; 
data out1; 
set out; 
if y=0; 
keep pred; 
run; 
data out2; 
set out; 
if y=1; 
keep pred; 
run; 
data out3; 
set out; 
if y=2; 
keep pred; 
run; 
proc iml; 
use out1; 
read all into x; 
close out1; 
use out2; 
read all into y; 
close out2; 
use out3; 
read all into z; 
close out3; 
n1=nrow(x);n2=nrow(y);n3=nrow(z); 
s=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
a=0;b=0;c=0; 
if x[i,]<=y[j,] then a=1; 
if y[j,]<=z[k,] then b=1; 
if x[i,]<=z[k,] then c=1; 
s=s+c*(a/3+1/3)*(b/3+1/3); 
end; 
end; 
end; 
vus=s/(n1*n2*n3); 
create vus var{vus}; 
append; 
close vus; 
quit; 
 
data auc; 
merge auc vus; 
run;  
 
data output_auc; 
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set output_auc auc; 
run;  
 
 
%mend; 
 
%macro sspec_10x(datain=, applydata=, var=, scale=); 
 
********************** 
find auc 
**********************; 
 
data cin1out; set &datain; if whole1 not in (2.5);whole = (whole1 > 2); run;  
data apply_cin1out; set &applydata; if whole1 not in (2.5); whole = (whole1 > 
2); run;  
 
 
proc pls data = cin1out cv=split(10); 
 model whole = &var; 
 output out=pred pred=pred; 
run; 
 
ods listing close; 
ods html close; 
ods trace off; 
 
ods output Association=auc; 
proc logistic data=pred; 
model high=pred; 
run; 
 
data auc; 
set auc; 
keep label2 nvalue2; 
if _n_=4; 
run; 
 
data auc; 
set auc; 
var="&var"; 
type='10x validation'; 
run; 
 
************************** 
find VUS 
**************************; 
 
proc pls data=combine cv=split(10); 
model y=&var; 
output out=out predicted=pred; 
run; 
data out1; 
set out; 
if y=0; 
keep pred; 
run; 
data out2; 
set out; 
if y=1; 
keep pred; 
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run; 
data out3; 
set out; 
if y=2; 
keep pred; 
run; 
proc iml; 
use out1; 
read all into x; 
close out1; 
use out2; 
read all into y; 
close out2; 
use out3; 
read all into z; 
close out3; 
n1=nrow(x);n2=nrow(y);n3=nrow(z); 
s=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
a=0;b=0;c=0; 
if x[i,]<=y[j,] then a=1; 
if y[j,]<=z[k,] then b=1; 
if x[i,]<=z[k,] then c=1; 
s=s+c*(a/3+1/3)*(b/3+1/3); 
end; 
end; 
end; 
vus=s/(n1*n2*n3); 
create vus var{vus}; 
append; 
close vus; 
quit; 
 
data auc; 
merge auc vus; 
run;  
 
data output_auc; 
set output_auc auc; 
run;  
%mend; 
 
/*model 1.03*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra78, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra78,scale=0); 
/*model 1.04*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra19 p25ra30-p25ra38 
p25ra59-p25ra68 p75ra20-p75ra29 p75ra39-p75ra58 p75ra69-p75ra78, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra19 p25ra30-
p25ra38 p25ra59-p25ra68 p75ra20-p75ra29 p75ra39-p75ra58 p75ra69-
p75ra78,scale=0); 
/*model 2.0*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra31, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra31,scale=0); 
/*model 2.1*/ 
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%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58,scale=0); 
/*model 2.11*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 sb1-sb11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 sb1-sb11,scale=0); 
/*model 2.12*/ 
 %sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 sbr1-sbr15, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 sbr1-sbr15,scale=0); 
/*model 2.13*/ 
 %sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 sbr16-sbr30, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 sbr16-sbr30,scale=0); 
/*model 2.14*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 sbr31-sbr45, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 sbr31-sbr45,scale=0); 
/*model 2.15*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 sbr46-sbr60, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 sbr46-sbr60,scale=0); 
/*model 2.20*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 sb12-sb22, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 sb12-sb22,scale=0); 
/*model 2.3*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 r1-r11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 r1-r11,scale=0); 
/*model 2.31*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57 p75ra58 r1-r11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 r1-r11,scale=0); 
/*model 2.32*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1 p25ra3 p25ra5 p25ra30 
p25ra32 p75ra25 p75ra27 p75ra29 p75ra57 p75ra58 r1-r8 r10 r11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1 p25ra3 p25ra5 p25ra30 
p25ra32 p75ra25 p75ra27 p75ra29 p75ra57 p75ra58 r1-r8 r10 r11,scale=0); 
/*model 2.33*/ 
%sspec(datain=combine, applydata=combine, var=p25ra3 p25ra31 p75ra27 p75ra29 
p75ra57 r2 r4 r5 r7 r8 r10 r11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra3 p25ra31 p75ra27 
p75ra29 p75ra57 r2 r4 r5 r7 r8 r10 r11,scale=0);  
/*model 2.35*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p75ra25-p75ra29 
p75ra57-p75ra58 r1-r11 gm1, scale=0); 
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%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p75ra25-
p75ra29 p75ra57-p75ra58 r1-r11 gm1,scale=0); 
/*model 2.36*/ 
 %sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p75ra25-p75ra29 
r1-r11 gm1 gm3, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p75ra25-
p75ra29 r1-r11 gm1 gm3,scale=0); 
/*model 2.37*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 r2 r4 r5 r6 r8 r9 r11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 r2 r4 r5 r6 r8 r9 r11,scale=0); 
/*model 2.39*/ 
%sspec(datain=combine, applydata=combine, var=p25ra4 p25ra5 p25ra30 p25ra31 
p25ra32 p75ra28 p75ra29 p75ra57 p75ra58 r1-r11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra4 p25ra5 p25ra30 
p25ra31 p25ra32 p75ra28 p75ra29 p75ra57 p75ra58 r1-r11,scale=0); 
/*model 2.40*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra58 r1 r2 r4 r6 r8 r9 r11, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra58 r1 r2 r4 r6 r8 r9 r11,scale=0); 
/*model 2.41*/  
%sspec(datain=combine, applydata=combine, var=p10ra30 p25ra32 dmr1-dmr11, 
scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p10ra30 p25ra32 dmr1-
dmr11,scale=0); 
/*model 2.42*/  
%sspec(datain=combine, applydata=combine, var=dmr1-dmr18, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=dmr1-dmr18,scale=0); 
/*model 2.43*/ 
%sspec(datain=combine, applydata=combine, var=dmr1-dmr18 d1-d8, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=dmr1-dmr18 d1-d8,scale=0); 
/*model 2.44*/ 
 %sspec(datain=combine, applydata=combine, var=p25ra1-p25ra4 p25ra30-p25ra32 
p75ra25-p75ra29 dmr1-dmr3 dmr5 dmr6 dmr9 dmr11 dmr14 dmr15 d1 d3 d4 d7, 
scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra4 p25ra30-
p25ra32 p75ra25-p75ra29 dmr1-dmr3 dmr5 dmr6 dmr9 dmr11 dmr14 dmr15 d1 d3 d4 
d7,scale=0); 
/*model 2.45*/ 
 %sspec(datain=combine, applydata=combine, var=p10m1 p25m1 p25m2 p50m1 p75m1 
p75m2 p90m1 p10_75m1 p10_75m2 p10_75m3 p10_75m4 p10_90m1 p10_90m2 p10_90m3 
p25_75m1 p25_75m2 p25_75m3 p25_75m4 p25_75m5 p25_90m1 p25_90m2 p25_90m3, 
scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p10m1 p25m1 p25m2 p50m1 
p75m1 p75m2 p90m1 p10_75m1 p10_75m2 p10_75m3 p10_75m4 p10_90m1 p10_90m2 
p10_90m3 p25_75m1 p25_75m2 p25_75m3 p25_75m4 p25_75m5 p25_90m1 p25_90m2 
p25_90m3,scale=0); 
/*model 2.46*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57-p75ra58 p10m1 p25m1 p25m2 p50m1 p75m1 p75m2 p90m1 
p10_75m1 p10_75m2 p10_75m3 p10_75m4 p10_90m1 p10_90m2 p10_90m3 p25_75m1 
p25_75m2 p25_75m3 p25_75m4 p25_75m5 p25_90m1 p25_90m2 p25_90m3, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57-p75ra58 p10m1 p25m1 p25m2 p50m1 p75m1 p75m2 
p90m1 p10_75m1 p10_75m2 p10_75m3 p10_75m4 p10_90m1 p10_90m2 p10_90m3 p25_75m1 
p25_75m2 p25_75m3 p25_75m4 p25_75m5 p25_90m1 p25_90m2 p25_90m3,scale=0); 
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/*model 2.47*/ 
%sspec(datain=combine, applydata=combine, var=p10m1 p25m1 p25m2 p75m2 p90m1 
p10_75m2 p10_90m1 p25_75m2 p25_75m4 p25_75m5 p25_90m3, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p10m1 p25m1 p25m2 p75m2 
p90m1 p10_75m2 p10_90m1 p25_75m2 p25_75m4 p25_75m5 p25_90m3,scale=0); 
/*model 2.48*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra29 p75ra57-p75ra58 p10m1 p25m1 p25m2 p75m2 p90m1 p10_75m2 
p10_90m1 p25_75m2 p25_75m4 p25_75m5 p25_90m3, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra29 p75ra57-p75ra58 p10m1 p25m1 p25m2 p75m2 p90m1 p10_75m2 
p10_90m1 p25_75m2 p25_75m4 p25_75m5 p25_90m3,scale=0); 
/*model 2.52*/ 
%sspec(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-p25ra32 
p75ra25-p75ra28 p75ra57 y1-y10, scale=0); 
%sspec_10x(datain=combine, applydata=combine, var=p25ra1-p25ra5 p25ra30-
p25ra32 p75ra25-p75ra28 p75ra57 y1-y10,scale=0); 
 
 
 
 
Theoretical VUS and U-statistics, bootstrap simulation for normal mu1=1 mu2=2 mu3=3, and 
sigma1=sigma2=sigma3=0.5 and sample size 40. For other cases, the code is similar. 
 
proc iml; 
a1=0.4;a2=0.2;a3=1-a1-a2; 
n1=40;n2=20;n3=40; 
mu1=1;mu2=2;mu3=3; 
sigma1=0.5;sigma2=0.5;sigma3=0.5; 
iteration=300;*simulation times; 
success=0; 
 
*find real VUS using Gaussian quadrature; 
LL1=mu1-3*sigma1;UL1=mu1+3*sigma1; 
LL2=mu2-3*sigma2;UL2=mu2+3*sigma2; 
LL3=mu3-3*sigma3;UL3=mu3+3*sigma3; 
w1=sqrt(5-2*sqrt(10/7))/3;w2=-sqrt(5-2*sqrt(10/7))/3; 
w3=sqrt(5+2*sqrt(10/7))/3;w4=-sqrt(5+2*sqrt(10/7))/3;w5=0; 
k11=(UL1-LL1)/2*w1+(LL1+UL1)/2;k12=(UL1-LL1)/2*w2+(LL1+UL1)/2; 
k13=(UL1-LL1)/2*w3+(LL1+UL1)/2;k14=(UL1-LL1)/2*w4+(LL1+UL1)/2;k15=(UL1-
LL1)/2*w5+(LL1+UL1)/2; 
k21=(UL2-LL2)/2*w1+(LL2+UL2)/2;k22=(UL2-LL2)/2*w2+(LL2+UL2)/2; 
k23=(UL2-LL2)/2*w3+(LL2+UL2)/2;k24=(UL2-LL2)/2*w4+(LL2+UL2)/2;k25=(UL2-
LL2)/2*w5+(LL2+UL2)/2; 
k31=(UL3-LL3)/2*w1+(LL3+UL3)/2;k32=(UL3-LL3)/2*w2+(LL3+UL3)/2; 
k33=(UL3-LL3)/2*w3+(LL3+UL3)/2;k34=(UL3-LL3)/2*w4+(LL3+UL3)/2;k35=(UL3-
LL3)/2*w5+(LL3+UL3)/2; 
f1=a2**2/((a1+a2)*(a2+a3))*probnorm((k21-mu1)/sigma1)*(1-probnorm((k21-
mu3)/sigma3))*pdf('normal',k21,mu2,sigma2)*(UL2-LL2)/2 
+a2*a3/(2*(a1+a2)*(a2+a3))*(1-probnorm((k11-mu2)/sigma2))*(1-probnorm((k11-
mu3)/sigma3))*pdf('normal',k11,mu1,sigma1)*(UL1-LL1)/2 
+a1*a2/(2*(a1+a2)*(a2+a3))*probnorm((k31-mu1)/sigma1)*probnorm((k31-
mu2)/sigma2)*pdf('normal',k31,mu3,sigma3)*(UL3-LL3)/2; 
f2=a2**2/((a1+a2)*(a2+a3))*probnorm((k22-mu1)/sigma1)*(1-probnorm((k22-
mu3)/sigma3))*pdf('normal',k22,mu2,sigma2)*(UL2-LL2)/2 
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+a2*a3/(2*(a1+a2)*(a2+a3))*(1-probnorm((k12-mu2)/sigma2))*(1-probnorm((k12-
mu3)/sigma3))*pdf('normal',k12,mu1,sigma1)*(UL1-LL1)/2 
+a1*a2/(2*(a1+a2)*(a2+a3))*probnorm((k32-mu1)/sigma1)*probnorm((k32-
mu2)/sigma2)*pdf('normal',k32,mu3,sigma3)*(UL3-LL3)/2; 
f3=a2**2/((a1+a2)*(a2+a3))*probnorm((k23-mu1)/sigma1)*(1-probnorm((k23-
mu3)/sigma3))*pdf('normal',k23,mu2,sigma2)*(UL2-LL2)/2 
+a2*a3/(2*(a1+a2)*(a2+a3))*(1-probnorm((k13-mu2)/sigma2))*(1-probnorm((k13-
mu3)/sigma3))*pdf('normal',k13,mu1,sigma1)*(UL1-LL1)/2 
+a1*a2/(2*(a1+a2)*(a2+a3))*probnorm((k33-mu1)/sigma1)*probnorm((k33-
mu2)/sigma2)*pdf('normal',k33,mu3,sigma3)*(UL3-LL3)/2; 
f4=a2**2/((a1+a2)*(a2+a3))*probnorm((k24-mu1)/sigma1)*(1-probnorm((k24-
mu3)/sigma3))*pdf('normal',k24,mu2,sigma2)*(UL2-LL2)/2 
+a2*a3/(2*(a1+a2)*(a2+a3))*(1-probnorm((k14-mu2)/sigma2))*(1-probnorm((k14-
mu3)/sigma3))*pdf('normal',k14,mu1,sigma1)*(UL1-LL1)/2 
+a1*a2/(2*(a1+a2)*(a2+a3))*probnorm((k34-mu1)/sigma1)*probnorm((k34-
mu2)/sigma2)*pdf('normal',k34,mu3,sigma3)*(UL3-LL3)/2; 
f5=a2**2/((a1+a2)*(a2+a3))*probnorm((k25-mu1)/sigma1)*(1-probnorm((k25-
mu3)/sigma3))*pdf('normal',k25,mu2,sigma2)*(UL2-LL2)/2 
+a2*a3/(2*(a1+a2)*(a2+a3))*(1-probnorm((k15-mu2)/sigma2))*(1-probnorm((k15-
mu3)/sigma3))*pdf('normal',k15,mu1,sigma1)*(UL1-LL1)/2 
+a1*a2/(2*(a1+a2)*(a2+a3))*probnorm((k35-mu1)/sigma1)*probnorm((k35-
mu2)/sigma2)*pdf('normal',k35,mu3,sigma3)*(UL3-LL3)/2; 
VUS=(f1+f2)*(322+13*sqrt(70))/900+(f3+f4)*(322-
13*sqrt(70))/900+f5*128/225+a1*a3/(4*(a1+a2)*(a2+a3))*probnorm((mu3-
mu1)/sqrt(sigma1**2+sigma3**2)); 
 
***************************************************; 
*U-statistics; 
***************************************************; 
 
do p=1 to iteration; 
 
*get random number; 
x=j(n1,1,0); 
y=j(n2,1,0); 
z=j(n3,1,0); 
do i=1 to n1; 
x[i,]=rand('normal',mu1,sigma1); 
end; 
do i=1 to n2; 
y[i,]=rand('normal',mu2,sigma2); 
end; 
do i=1 to n3; 
z[i,]=rand('normal',mu3,sigma3); 
end; 
 
*find estimate VUS and variance using non-parametric method; 
VUS_hat=0;sigma111=0;sigma100=0;sigma010=0;sigma001=0;sigma110=0;sigma101=0;si
gma011=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
if x[i,]<=y[j,] then s1=1;else s1=0; 
if y[j,]<=z[k,] then s2=1;else s2=0; 
if x[i,]<=z[k,] then s3=1;else s3=0; 
 
do l=1 to n2; 
do m=1 to n3; 
if x[i,]<=y[l,] then s_11=1;else s_11=0; 
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if y[l,]<=z[m,] then s_12=1;else s_12=0; 
if x[i,]<=z[m,] then s_13=1;else s_13=0; 
sigma100=sigma100+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2))
)*s3*(a2/(a2+a3)*s_12+a3/(2*(a2+a3)))*(a2/(a1+a2)*s_11+a1/(2*(a1+a2)))*s_13; 
end; 
end; 
 
do l=1 to n1; 
do m=1 to n3; 
if x[l,]<=y[j,] then s_21=1;else s_21=0; 
if y[j,]<=z[m,] then s_22=1;else s_22=0; 
if x[l,]<=z[m,] then s_23=1;else s_23=0; 
sigma010=sigma010+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2))
)*s3*(a2/(a2+a3)*s_22+a3/(2*(a2+a3)))*(a2/(a1+a2)*s_21+a1/(2*(a1+a2)))*s_23; 
end; 
end; 
 
do l=1 to n1; 
do m=1 to n2; 
if x[l,]<=y[m,] then s_31=1;else s_31=0; 
if y[m,]<=z[k,] then s_32=1;else s_32=0; 
if x[l,]<=z[k,] then s_33=1;else s_33=0; 
sigma001=sigma001+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2))
)*s3*(a2/(a2+a3)*s_32+a3/(2*(a2+a3)))*(a2/(a1+a2)*s_31+a1/(2*(a1+a2)))*s_33; 
end; 
end; 
 
do l=1 to n3; 
if x[i,]<=y[j,] then s_41=1;else s_41=0; 
if y[j,]<=z[l,] then s_42=1;else s_42=0; 
if x[i,]<=z[l,] then s_43=1;else s_43=0; 
sigma110=sigma110+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2))
)*s3*(a2/(a2+a3)*s_42+a3/(2*(a2+a3)))*(a2/(a1+a2)*s_41+a1/(2*(a1+a2)))*s_43; 
end; 
 
do l=1 to n2; 
if x[i,]<=y[l,] then s_51=1;else s_51=0; 
if y[l,]<=z[k,] then s_52=1;else s_52=0; 
if x[i,]<=z[k,] then s_53=1;else s_53=0; 
sigma101=sigma101+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2))
)*s3*(a2/(a2+a3)*s_52+a3/(2*(a2+a3)))*(a2/(a1+a2)*s_51+a1/(2*(a1+a2)))*s_53; 
end; 
 
do l=1 to n1; 
if x[l,]<=y[j,] then s_61=1;else s_61=0; 
if y[j,]<=z[k,] then s_62=1;else s_62=0; 
if x[l,]<=z[k,] then s_63=1;else s_63=0; 
sigma011=sigma011+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2))
)*s3*(a2/(a2+a3)*s_62+a3/(2*(a2+a3)))*(a2/(a1+a2)*s_61+a1/(2*(a1+a2)))*s_63; 
end; 
 
VUS_hat=VUS_hat+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2)))*
s3; 
sigma111=sigma111+((a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2)
))*s3)**2; 
 
end; 
end; 
end; 
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VUS_hat=VUS_hat/(n1*n2*n3); 
sigma111=sigma111/(n1*n2*n3); 
sigma100=sigma100/(n1*n2*n3*n2*n3); 
sigma010=sigma010/(n1*n2*n3*n1*n3); 
sigma001=sigma001/(n1*n2*n3*n1*n2); 
sigma110=sigma110/(n1*n2*n3*n3); 
sigma101=sigma101/(n1*n2*n3*n2); 
sigma011=sigma011/(n1*n2*n3*n1); 
variance=(sigma111-VUS_hat**2)/(n1*n2*n3)+(sigma100-VUS_hat**2)*(n2-1)*(n3-
1)/(n1*n2*n3) 
        +(sigma010-VUS_hat**2)*(n1-1)*(n3-1)/(n1*n2*n3)+(sigma001-
VUS_hat**2)*(n1-1)*(n2-1)/(n1*n2*n3) 
        +(sigma110-VUS_hat**2)*(n3-1)/(n1*n2*n3)+(sigma101-VUS_hat**2)*(n2-
1)/(n1*n2*n3) 
        +(sigma011-VUS_hat**2)*(n1-1)/(n1*n2*n3); 
 
*find the coverage rate; 
Low=VUS_hat-1.96*sqrt(variance); 
High=VUS_hat+1.96*sqrt(variance); 
if VUS<=High & VUS>=Low then success=success+1; 
end; 
coverage_rate=success/iteration; 
print success coverage_rate VUS; 
quit; 
 
***************************************************; 
*bootstrap; 
***************************************************; 
do p=1 to iteration; 
 
*get random number; 
x=j(n1,1,0); 
y=j(n2,1,0); 
z=j(n3,1,0); 
do i=1 to n1; 
x[i,]=rand('normal',mu1,sigma1); 
end; 
do i=1 to n2; 
y[i,]=rand('normal',mu2,sigma2); 
end; 
do i=1 to n3; 
z[i,]=rand('normal',mu3,sigma3); 
end; 
 
*find estimate VUS and Confidence interval using Bootstrap method; 
VUS_hat=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
if x[i,]<=y[j,] then s1=1;else s1=0; 
if y[j,]<=z[k,] then s2=1;else s2=0; 
if x[i,]<=z[k,] then s3=1;else s3=0; 
VUS_hat=VUS_hat+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2)))*
s3; 
end; 
end; 
end; 
VUS_hat=VUS_hat/(n1*n2*n3); 
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VUS_resample=j(200,1,0); 
do b=1 to 200; 
x_b=j(n1,1,0); 
y_b=j(n2,1,0); 
z_b=j(n3,1,0); 
do i=1 to n1; 
r_number=int(rand('Uniform')*n1)+1; 
x_b[i,]=x[r_number,]; 
end; 
do j=1 to n2; 
r_number=int(rand('Uniform')*n2)+1; 
y_b[j,]=y[r_number,]; 
end; 
do k=1 to n3; 
r_number=int(rand('Uniform')*n3)+1; 
z_b[k,]=z[r_number,]; 
end; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
if x_b[i,]<=y_b[j,] then s1=1;else s1=0; 
if y_b[j,]<=z_b[k,] then s2=1;else s2=0; 
if x_b[i,]<=z_b[k,] then s3=1;else s3=0; 
VUS_resample[b,]=VUS_resample[b,]+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s
1+a1/(2*(a1+a2)))*s3; 
end; 
end; 
end; 
VUS_resample[b,]=VUS_resample[b,]/(n1*n2*n3); 
end; 
VUS_resample1=VUS_resample;  
VUS_resample[rank(VUS_resample),]=VUS_resample1;  
 
*find the coverage rate; 
Low=VUS_resample[5,]; 
High=VUS_resample[195,]; 
if VUS<=High & VUS>=Low then success=success+1; 
end; 
coverage_rate=success/iteration; 
print success coverage_rate VUS; 
quit; 
 
 
descriptive Study for Composite IQ. For other variables, the code is similar 
 
proc import datafile='D:\My Documents\Mixed model\SB_long_yusheng.xls' 
out=alldata replace; 
run; 
proc import datafile='D:\My Documents\Mixed model\SB_long_yusheng_adj.xls' 
out=adjdata replace; 
run; 
data alldata; 
set alldata; 
keep idnum age_diagnosis_years time_since_diagnosis_years sex SES  
Radiation Chemotherapy NPS_Total vrsas avrsas qrsas stmsas compiq; 
rename age_diagnosis_years=age time_since_diagnosis_years=time; 
run; 
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data adjdata; 
set adjdata; 
keep idnum age_diagnosis_years time_since_diagnosis_years sex SES  
Radiation Chemotherapy NPS_Total vrsas avrsas qrsas stmsas compiq; 
rename age_diagnosis_years=age time_since_diagnosis_years=time; 
run; 
data alldata; 
set alldata; 
age_group=age>7; 
run; 
data adjdata; 
set adjdata; 
age_group=age>7; 
run; 
ods output Freq.Table1.OneWayFreqs=d1; 
proc freq data=alldata; 
table idnum; 
run; 
ods output Freq.Table1.OneWayFreqs=d2; 
proc freq data=adjdata; 
table idnum; 
run; 
proc means data=adjdata noprint; 
var radiation chemotherapy sex age_group SES; 
by idnum; 
output out=mean; 
run; 
data mean; 
set mean; 
if _STAT_='MEAN'; 
radiation=(radiation>0); 
chemotherapy=(chemotherapy>0); 
run; 
proc freq data=adjdata; 
table SES; 
run; 
proc univariate data=adjdata; 
var NPS_total age time; 
run; 
data d2; 
set d2; 
if frequency=2 then f=2; 
else if frequency=3 then f=3; 
else if frequency=4 then f=4; 
else f=5; 
run; 
proc freq data=d2; 
table f; 
run; 
 
******************************************** 
Individual Composite IQ score trajectories 
********************************************; 
 
goption reset=all; 
symbol interpol=join  repeat=300  ; 
proc gplot data=adjdata; 
     plot compiq* time=idnum; 
     run;quit; 
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Model construction, WAPRESS and VUS for Composite IQ NPS hierarchical linear model. For 
other linear/quatratic models, the code is similar 
 
****************************** 
Model construction and WAPRESS 
******************************; 
 
proc import datafile='D:\My documents\Mixed model\SB_long_yusheng_adj.xls' 
out=alldata replace; 
run; 
data alldata; 
set alldata; 
keep idnum age_diagnosis_years time_since_diagnosis_years sex SES  
Radiation Chemotherapy NPS_Total vrsas avrsas qrsas stmsas compiq; 
rename age_diagnosis_years=age time_since_diagnosis_years=time NPS_total=NPS 
Chemotherapy=chemo Radiation=rad; 
run; 
data alldata; 
set alldata; 
age_g=age>7; 
time2=time**2; 
compiq_=compiq; 
run; 
 
data alldata; 
retain index 0; 
set alldata;by idnum; 
if first.idnum then index=index+1; 
run; 
 
data out; 
set _null_; 
run; 
 
%macro press; 
%do i=1 %to 95; 
 
data data&i; 
set alldata; 
if index=&i then compiq=.; 
run; 
ods output  SolutionF=est&i; 
proc mixed data=data&i covtest; 
    model compiq= age_g SES NPS time  
                 NPS*time 
                  /s outpred=out&i; 
    random intercept time/s  type=un;  
    run;                            
data out&i; 
set out&i; 
if index=&i; 
run; 
data out; 
set out out&i; 
run; 
%end; 
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%mend; 
%press; 
data out; 
set out;; 
se=(compiq_-pred)**2; 
run; 
proc means data=out noprint; 
var se; 
by idnum; 
output out=out_1 mean=average; 
run; 
proc means sum data=out_1; 
var average; 
run; 
****************************** 
VUS calculation 
******************************; 
 
proc import datafile='D:\My Documents\Mixed model\SB_long_yusheng_adj.xls' 
out=alldata replace; 
run; 
data alldata; 
set alldata; 
keep idnum age_diagnosis_years time_since_diagnosis_years sex SES  
Radiation Chemotherapy NPS_Total vrsas avrsas qrsas stmsas compiq; 
rename age_diagnosis_years=age time_since_diagnosis_years=time NPS_total=NPS 
Chemotherapy=chemo Radiation=rad; 
run; 
data alldata; 
set alldata; 
age_g=age>7; 
time2=time**2; 
run; 
ods output SolutionF=est; 
proc mixed data=alldata covtest; 
    model compiq= ses age_g NPS time 
                 NPS*time    
                    /s outpred=out1; 
    random intercept time/s  type=un subject=idnum;  
    run; 
 
data est; 
set est (keep=effect estimate); 
run; 
proc transpose data=est out=estimate; 
var estimate; 
id effect; 
run; 
data out; 
set alldata; 
_name_="Estimate"; 
run;       
data estimate; 
set estimate; 
rename ses=ses_e age_g=age_g_e NPS=NPS_e time=time_e; 
run;  
data out; 
merge out estimate; 
by _name_; 
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run; 
data out; 
set out; 
y=intercept+ses_e*ses+age_g_e*age_g+NPS_e*NPS+NPS_time*NPS*time+time_e*time; 
run; 
 
*************** 
3-level VUS 
***************; 
proc iml; 
use out var{compiq y}; 
read all var{y} where(compiq<86) into x; 
read all var{y} where(compiq>=86 & compiq<101) into y; 
read all var{y} where(compiq>=101) into z; 
close out; 
n1=nrow(x);n2=nrow(y);n3=nrow(z); 
s=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
a=0;b=0;c=0; 
if x[i,]<=y[j,] then a=1; 
if y[j,]<=z[k,] then b=1; 
if x[i,]<=z[k,] then c=1; 
s=s+c*(a/2+1/4)*(b/2+1/4); 
end; 
end; 
end; 
vus=s/(n1*n2*n3); 
print vus; 
create vus var{vus}; 
append; 
close vus; 
quit; 
 
*************** 
4-level VUS 
***************; 
proc iml; 
use out var{compiq y}; 
read all var{y} where(compiq<82) into x1; 
read all var{y} where(compiq>=82 & compiq<94) into x2; 
read all var{y} where(compiq>=94 & compiq<105) into x3; 
read all var{y} where(compiq>=105) into x4; 
close out; 
n1=nrow(x1);n2=nrow(x2);n3=nrow(x3);n4=nrow(x4); 
sum=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
do l=1 to n4; 
a=(x1[i,]<=x2[j,]); 
b=(x1[i,]<=x3[k,]); 
c=(x1[i,]<=x4[l,]); 
d=(x2[j,]<=x3[k,]); 
e=(x2[j,]<=x4[l,]); 
f=(x3[k,]<=x4[l,]); 
sum=sum+c*(3*a*d*f+a*f+(b*f+a*e+a*d*e+b*d*f)/2+(a+f+a*d+d*f)/3+b*e/4+(b+e)/6+1
/9)/36; 
end; 
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end; 
end; 
end; 
vus=sum/(n1*n2*n3*n4); 
print vus; 
create vus var{vus}; 
append; 
close vus; 
quit; 
 
 
Model construction, WAPRESS and VUS for Composite IQ NPS Compertz model. For other 
linear/quatratic models, the code is similar 
 
****************************** 
Model construction and WAPRESS 
******************************; 
 
proc import datafile='H:\Mixed model\SB_long_yusheng_adj.xls' out=alldata 
replace; 
run; 
data alldata; 
set alldata; 
keep idnum age_diagnosis_years time_since_diagnosis_years sex SES  
Radiation Chemotherapy NPS_Total vrsas avrsas qrsas stmsas compiq; 
rename age_diagnosis_years=age time_since_diagnosis_years=time; 
run; 
data alldata; 
set alldata; 
age_group=age>7; 
run; 
 
data alldata; 
retain index 0; 
set alldata;by idnum; 
if first.idnum then index=index+1; 
run; 
 
data estimate; 
set _null_; 
run; 
 
%macro press; 
%do i=1 %to 95; 
 
data data&i; 
set alldata; 
if index=&i then delete; 
run; 
ods output  ParameterEstimates=est&i; 
proc nlmixed data=data&i; 
parms beta01=0.5 beta11=0.5 beta61=0.5 
      beta32=0.5 beta62=0.5 
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      beta13=0.5 beta33=0.5  
      sigmae=.5 sigmau1=.5 sigmau2=.5 sigmau12=0;  
b1=beta01+age_group*beta11+NPS_total*beta61+u1; 
b2=SES*beta32+NPS_total*beta62+u2; 
b3=age_group*beta13+SES*beta33; 
yhat=b1-b2*exp(-b3*time); 
compiqhat=exp(yhat); 
y=log(compiq); 
model y~normal(yhat,sigmae); 
random u1 u2~normal([0,0],[sigmau1,sigmau12,sigmau2]) subject=idnum; 
run; 
data est&i; 
set est&i (keep=parameter estimate); 
run; 
proc transpose data=est&i out=estimate&i; 
var estimate; 
id parameter; 
run; 
data estimate&i; 
set estimate&i; 
index=&i; 
run; 
data estimate; 
set estimate estimate&i; 
run; 
%end; 
%mend; 
%press; 
data alldata; 
merge alldata estimate; 
by index; 
run; 
 
data alldata; 
set alldata; 
b1=beta01+age_group*beta11+NPS_total*beta61; 
b2=SES*beta32+NPS_total*beta62; 
b3=age_group*beta13+SES*beta33; 
y=exp(b1-b2*exp(-b3*time)+0.5*(sigmau1+sigmau2*exp(-2*b3*time)-2*exp(-
b3*time)*sigmau12+sigmae)); 
se=(y-compiq)**2; 
run; 
proc means data=alldata noprint; 
var se; 
by idnum; 
output out=out_1 mean=average; 
run; 
proc means sum data=out_1; 
var average; 
run; 
****************************** 
VUS calculation 
******************************; 
 
proc import datafile='D:\My documents\Mixed model\SB_long_yusheng_adj.xls' 
out=alldata replace; 
run; 
data alldata; 
set alldata; 
keep idnum age_diagnosis_years time_since_diagnosis_years sex SES  
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Radiation Chemotherapy NPS_Total vrsas avrsas qrsas stmsas compiq; 
rename age_diagnosis_years=age time_since_diagnosis_years=time NPS_total=NPS 
Chemotherapy=chemo Radiation=rad; 
run; 
data alldata; 
set alldata; 
age_g=age>7; 
run; 
ods output  ParameterEstimates=est; 
proc nlmixed data=alldata method=firo; 
parms beta01=0.5 beta11=0.5 beta21=0.5            beta41=0.5 
      beta02=0.5            beta22=0.5            beta42=0.5       
                            beta23=0.5 beta33=0.5 beta43=0.5                                 
      sigmae=.5 sigmau1=.5;  
b1=beta01+age_g*beta11+SES*beta21           +NPS*beta41+u1; 
b2=beta02             +SES*beta22           +NPS*beta42; 
b3=                    SES*beta23+sex*beta33+NPS*beta43; 
yhat=b1-b2*exp(-b3*time); 
compiqhat=exp(yhat); 
y=log(compiq); 
model y~normal(yhat,sigmae); 
random u1~normal(0,sigmau1) subject=idnum; 
predict compiqhat out=out; 
run; 
data est; 
set est (keep=parameter estimate); 
run; 
proc transpose data=est out=estimate; 
var estimate; 
id parameter; 
run; 
data out; 
set out; 
_name_="Estimate"; 
run; 
data out; 
merge out estimate; 
by _name_; 
run; 
data out; 
set out; 
b0=beta01+age_g*beta11+SES*beta21           +NPS*beta41; 
b1=beta02             +SES*beta22           +NPS*beta42; 
b2=                    SES*beta23+sex*beta33+NPS*beta43; 
y=exp(b0-b1*exp(-b2*time)+0.5*(sigmau1+sigmae)); 
run;              
*************** 
3-level VUS 
***************; 
proc iml; 
use out var{compiq y}; 
read all var{y} where(compiq<86) into x; 
read all var{y} where(compiq>=86 & compiq<101) into y; 
read all var{y} where(compiq>=101) into z; 
close out; 
n1=nrow(x);n2=nrow(y);n3=nrow(z); 
s=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
136 
 
a=0;b=0;c=0; 
if x[i,]<=y[j,] then a=1; 
if y[j,]<=z[k,] then b=1; 
if x[i,]<=z[k,] then c=1; 
s=s+c*(a/2+1/4)*(b/2+1/4); 
end; 
end; 
end; 
vus=s/(n1*n2*n3); 
print vus; 
create vus var{vus}; 
append; 
close vus; 
quit; 
 
*************** 
4-level VUS 
***************; 
proc iml; 
use out var{compiq y}; 
read all var{y} where(compiq<82) into x1; 
read all var{y} where(compiq>=82 & compiq<94) into x2; 
read all var{y} where(compiq>=94 & compiq<105) into x3; 
read all var{y} where(compiq>=105) into x4; 
close out; 
n1=nrow(x1);n2=nrow(x2);n3=nrow(x3);n4=nrow(x4); 
sum=0; 
do i=1 to n1; 
do j=1 to n2; 
do k=1 to n3; 
do l=1 to n4; 
a=(x1[i,]<=x2[j,]); 
b=(x1[i,]<=x3[k,]); 
c=(x1[i,]<=x4[l,]); 
d=(x2[j,]<=x3[k,]); 
e=(x2[j,]<=x4[l,]); 
f=(x3[k,]<=x4[l,]); 
sum=sum+c*(3*a*d*f+a*f+(b*f+a*e+a*d*e+b*d*f)/2+(a+f+a*d+d*f)/3+b*e/4+(b+e)/6+1
/9)/36; 
end; 
end; 
end; 
end; 
vus=sum/(n1*n2*n3*n4); 
print vus; 
create vus var{vus}; 
append; 
close vus; 
quit; 
 
 
 
 
137 
 
################################################################# 
R-code for one example of Empircal likelihood Inference for VUS 
################################################################# 
#simulation parameter 
 
Sim=1                #simulation number 
loop=10              #solving equation system loop number 
VUS=0.3029789        #Theoritical VUS 
a1=2 
a2=1 
a3=2 
n1=16     #sample size X 
n2=8      #sample size Y 
n3=16     #sample size Z   
 
 
# construct necessary functions 
 
H=function(x1,x2,x3,theta) 
(a2^2*(x1<=x2)*(x2<=x3)+a2*a3/2*(x1<=x2)*(x1<=x3)+a1*a2/2*(x1<=x3)*(x2<=x3)+a1*a3/4*(x1<=x3))/((a2+a
3)*(a1+a2))-theta 
 
Hi..=function(u2,u3,theta){ 
S=rep(0,n1) 
for(i in 1:n1)for(q in 1:n2)for(r in 1:n3)S[i]=S[i]+u2[q]*u3[r]*H(x[i],y[q],z[r],theta) 
return(S) 
} 
H.j.=function(u1,u3,theta){ 
S=rep(0,n2) 
for(j in 1:n2)for(p in 1:n1)for(r in 1:n3)S[j]=S[j]+u1[p]*u3[r]*H(x[p],y[j],z[r],theta) 
return(S) 
} 
H..k=function(u1,u2,theta){ 
S=rep(0,n3) 
for(k in 1:n3)for(p in 1:n1)for(q in 1:n2)S[k]=S[k]+u1[p]*u2[q]*H(x[p],y[q],z[k],theta) 
return(S) 
} 
lamda.restrict=function(u1,u2,u3,theta){ 
S=0 
for(i in 1:n1)for(j in 1:n2)for(k in 1:n3)S=S+u1[i]*u2[j]*u3[k]*H(x[i],y[j],z[k],theta) 
return(S) 
} 
log.lik=function(u1,u2,u3,lamda,theta) 
2*sum(log(abs(1+lamda/n1*Hi..(u2,u3,theta))))+2*sum(log(abs(1+lamda/n2*H.j.(u1,u3,theta))))+2*sum(log(abs(1+
lamda/n3*H..k(u1,u2,theta)))) 
 
g1=function(w) 
sum((w[1:n1]-
1/(n1+w[n1+n2+n3+1]*Hi..(w[(n1+1):(n1+n2)],w[(n1+n2+1):(n1+n2+n3)],w[n1+n2+n3+2])))^2)+sum((w[(n1+1):(
n1+n2)]-
1/(n2+w[n1+n2+n3+1]*H.j.(w[1:n1],w[(n1+n2+1):(n1+n2+n3)],w[n1+n2+n3+2])))^2)+sum((w[(n1+n2+1):(n1+n2+
n3)]-
1/(n3+w[n1+n2+n3+1]*H..k(w[1:n1],w[(n1+1):(n1+n2)],w[n1+n2+n3+2])))^2)+lamda.restrict(w[1:n1],w[(n1+1):(n
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1+n2)],w[(n1+n2+1):(n1+n2+n3)],w[n1+n2+n3+2])^2+(log.lik(w[1:n1],w[(n1+1):(n1+n2)],w[(n1+n2+1):(n1+n2+n
3)],w[n1+n2+n3+1],w[n1+n2+n3+2])-qchisq(0.95,1))^2 
 
 
Cover=0 
length=0 
 
for(q in 1:Sim){ 
x=rnorm(n1,mean=1,sd=1.25) 
y=rnorm(n2,mean=2,sd=1.25) 
z=rnorm(n3,mean=3,sd=1.25) 
 
#find estimate VUS  
VUS_hat=0 
for( i in 1:n1) 
for( j in 1:n2) 
for( k in 1:n3) 
{ 
s1=x[i]<=y[j] 
s2=y[j]<=z[k]  
s3=x[i]<=z[k] 
VUS_hat=VUS_hat+(a2/(a2+a3)*s2+a3/(2*(a2+a3)))*(a2/(a1+a2)*s1+a1/(2*(a1+a2)))*s3 
} 
VUS_hat=VUS_hat/(n1*n2*n3) 
 
# estimate confidence limit 
 
NA.LL=VUS_hat-1.96*0.03 
NA.UL=VUS_hat+1.96*0.03 
 
##################Empirical likelihood################ 
 
#construct EL CI by solving nonlinear equation system 
 
 
u1=rep(1/n1,n1) 
u2=rep(1/n2,n2) 
u3=rep(1/n3,n3) 
EL.LL=rep(NA,loop) 
parameter=c(0,NA.LL) 
for (p in 1:loop){ 
H1=Hi..(u2,u3,0) 
H11=0 
for(j in 1:n2)for(k in 1:n3)H11=H11+u2[j]*u3[k] 
H2=H.j.(u1,u3,0) 
H22=0 
for(i in 1:n1)for(k in 1:n3)H22=H22+u1[i]*u3[k] 
H3=H..k(u1,u2,0) 
H33=0 
for(i in 1:n1)for(j in 1:n2)H33=H33+u1[i]*u2[j] 
H4=lamda.restrict(u1,u2,u3,0) 
H44=0 
for(i in 1:n1)for(j in 1:n2)for(k in 1:n3)H44=H44+u1[i]*u2[j]*u3[k] 
g2=function(par)(2*sum(log(abs(1+par[1]/n1*(H1-par[2]*H11))))+2*sum(log(abs(1+par[1]/n2*(H2-
par[2]*H22))))+2*sum(log(abs(1+par[1]/n3*(H3-par[2]*H33))))-qchisq(0.95,1))^2+(H4-par[2]*H44)^2 
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parameter=nlm(g2,parameter)$estimate 
EL.LL[p]=parameter[2] 
u1=1/(n1+parameter[1]*Hi..(u2,u3,parameter[2])) 
u2=1/(n2+parameter[1]*H.j.(u1,u3,parameter[2])) 
u3=1/(n3+parameter[1]*H..k(u1,u2,parameter[2])) 
} 
ELT.LL=EL.LL[loop] #EL lower limit 
 
u1=rep(1/n1,n1) 
u2=rep(1/n2,n2) 
u3=rep(1/n3,n3) 
EL.UL=rep(NA,loop) 
parameter=c(0,NA.UL) 
for (p in 1:loop){ 
H1=Hi..(u2,u3,0) 
H11=0 
for(j in 1:n2)for(k in 1:n3)H11=H11+u2[j]*u3[k] 
H2=H.j.(u1,u3,0) 
H22=0 
for(i in 1:n1)for(k in 1:n3)H22=H22+u1[i]*u3[k] 
H3=H..k(u1,u2,0) 
H33=0 
for(i in 1:n1)for(j in 1:n2)H33=H33+u1[i]*u2[j] 
H4=lamda.restrict(u1,u2,u3,0) 
H44=0 
for(i in 1:n1)for(j in 1:n2)for(k in 1:n3)H44=H44+u1[i]*u2[j]*u3[k] 
g2=function(par)(2*sum(log(abs(1+par[1]/n1*(H1-par[2]*H11))))+2*sum(log(abs(1+par[1]/n2*(H2-
par[2]*H22))))+2*sum(log(abs(1+par[1]/n3*(H3-par[2]*H33))))-qchisq(0.95,1))^2+(H4-par[2]*H44)^2 
parameter=nlm(g2,parameter)$estimate 
EL.UL[p]=parameter[2] 
u1=1/(n1+parameter[1]*Hi..(u2,u3,parameter[2])) 
u2=1/(n2+parameter[1]*H.j.(u1,u3,parameter[2])) 
u3=1/(n3+parameter[1]*H..k(u1,u2,parameter[2])) 
} 
ELT.UL=EL.UL[loop] #EL upper limit 
 
length=length+(ELT.UL-ELT.LL) 
if(ELT.LL<=VUS & VUS<=ELT.UL)Cover=Cover+1 
} 
Coverage=Cover/Sim 
length=length/Sim 
Coverage 
length 
 
